STOCK TITAN

Pelagos Insurance Q3 net income falls to $61.7M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

Pelagos Insurance Capital Limited reported results for the three and nine months ended September 30, 2026. Third-quarter gross premiums written were $839.8 million, up 5.3% from the third quarter of 2025. Net income was $61.7 million versus $130.5 million in the prior-year quarter, while operating net income was $83.3 million versus $126.8 million. The combined ratio was 91.5%, compared with 79.0% in the third quarter of 2025; underwriting income was $67.0 million versus $125.5 million. Catastrophe and large losses were $115.9 million, compared with $57.4 million.

For the nine months ended September 30, 2026, gross premiums written were $3,977.0 million, up 6.4% from 2025. Net income was $214.1 million versus $107.7 million, and operating net income was $200.4 million versus $95.2 million. The combined ratio improved to 92.4% from 99.5%, and annualized operating ROAE rose to 11.8% from 5.2%. Pelagos returned $400.5 million, including $362.5 million of repurchases and $38.0 million in dividends. The board approved an increase in the quarterly dividend to $0.22 per common share, payable December 23, 2026, to holders of record December 11, 2026.

4 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 3 points

How the balance works

Positive

  • Moderate pointNine-month net income rose to $214.1 million from $107.7 million.
  • Moderate pointNine-month combined ratio improved 7 points to 92.4%.
  • Moderate pointAnnualized Operating ROAE improved 7 points to 11.8%.
  • Minor pointQuarterly dividend increased to $0.22 per common share.

Negative

  • Moderate pointThird-quarter net income was $61.7 million, down from $130.5 million.
  • Moderate pointThird-quarter combined ratio increased to 91.5% from 79.0%.
  • Moderate pointCatastrophe and large losses increased to $115.9 million from $57.4 million. 5% of market cap

Filing Explained

The $400 million figure is authorization, not completed repurchasing; the filing incorporates its financial statements and MD&A into Pelagos's registration statements.

This 6-K incorporates the financial statements and MD&A (Exhibit 99.2), but not the press release or presentation, into Pelagos's Form S-8 and Form F-3 registration statements.

The board's November 3, 2026 approval replenished the share-repurchase authorization to $400 million; the filing presents this as authorization rather than completed repurchases.

At September 30, 2026, Pelagos reported 79,345,285 common shares issued and outstanding, compared with 96,651,534 at December 31, 2025.

Gross premiums written $839.8 million Three months ended September 30, 2026; $797.5 million in the same 2025 period
Net income $61.7 million Three months ended September 30, 2026; $130.5 million in the same 2025 period
Combined ratio 91.5% Three months ended September 30, 2026; 79.0% in the same 2025 period
Catastrophe and large losses $115.9 million Three months ended September 30, 2026; $57.4 million in the same 2025 period
Gross premiums written $3,977.0 million Nine months ended September 30, 2026; $3,739.4 million in the same 2025 period
Net income $214.1 million Nine months ended September 30, 2026; $107.7 million in the same 2025 period
Combined ratio 92.4% Nine months ended September 30, 2026; 99.5% in the same 2025 period
Quarterly dividend per common share $0.22 per common share Board-approved increase; payable December 23, 2026
Gross premiums written financial
"Gross premiums written of $839.8 million"
Gross premiums written is the total dollar value of all insurance policies an insurer issues or renews over a period, measured before subtracting amounts passed on to other insurers (reinsurance) or cancellations. Think of it as a store’s total receipts from sales before returns and wholesaler fees; it shows how much business the company is generating but not how much it keeps as profit, so investors use it to gauge growth and market activity.
Combined ratio financial
"the combined ratio was 91.5%"
The combined ratio is a way insurance companies measure how well they are doing by adding up all their costs and claims and comparing them to the money they earn from premiums. If the ratio is below 100%, it means the company is making a profit; if it's above 100%, they are losing money. It helps see if an insurance company is financially healthy or not.
Annualized Operating ROAE financial
"Annualized Operating ROAE of 15.3%"
A percentage that shows how much profit a company’s core business activities generate for shareholders, measured against the average shareholder equity and adjusted to represent a full year. “Operating” excludes non-recurring gains or financing items, and “annualized” scales partial‑period results to a yearly rate. Investors use it to judge how efficiently equity is turned into recurring operating profit—like comparing the yearly crop from the same number of seeds—while being mindful of one‑off items that can distort the number.
Operating net income financial
"Operating net income was $83.3 million"
accumulated other comprehensive income/(loss) financial
"accumulated other comprehensive income/(loss) (“AOCI”)"
Accumulated other comprehensive income/(loss) is a cumulative subtotal within shareholders’ equity that records certain unrealized gains and losses that bypass the income statement, such as foreign currency translation adjustments, unrealized gains or losses on available-for-sale securities or cash-flow hedges, and actuarial gains or losses on defined-benefit pension plans. These amounts accumulate over time until a triggering event (for example, sale of the investment or settlement of a hedge) causes a reclassification adjustment into net income; they change equity but are separate from retained earnings and current-period net income.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were PLGO's third-quarter 2026 earnings?

PLGO reported net income of $61.7 million, or $0.74 per diluted common share, for the three months ended September 30, 2026. Operating net income was $83.3 million, or $1.00 per diluted common share, and gross premiums written were $839.8 million.

How much did PLGO's gross premiums written increase in the first nine months of 2026?

Gross premiums written were $3,977.0 million for the nine months ended September 30, 2026, up 6.4% from $3,739.4 million in the same 2025 period. Net income for the 2026 period was $214.1 million, compared with $107.7 million in 2025.

When is PLGO's quarterly dividend payable?

PLGO's board approved an increase to $0.22 per common share and declared the quarterly dividend payable on December 23, 2026, to common shareholders of record on December 11, 2026.

How many shares did PLGO repurchase in the first nine months of 2026?

PLGO repurchased 17,707,715 common shares in the nine months ended September 30, 2026, for $362.5 million, excluding expenses, at an average price of $20.47 per share under its share repurchase authorization.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the Month of November 2026
Commission File Number: 001-41731
PELAGOS INSURANCE CAPITAL LIMITED
(Exact Name of Registrant as Specified in its Charter)
90 Pitts Bay Road, Wellesley House South, Pembroke, Bermuda, HM08
+1 441 279 2590

(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒    Form 40-F ☐










On November 11, 2026, Pelagos Insurance Capital Limited (the “Company”) issued a press release, and consolidated financial statements and the management’s discussion and analysis announcing results for the three and nine months ended September 30, 2026, which are attached hereto as Exhibits 99.1 and 99.2, respectively, to this Report of Foreign Issuer on Form 6-K (this “Report”).

The Company is also making available a Company slide presentation, which is attached as Exhibit 99.3 to this Report.

This Report (including the information contained in Exhibit 99.2 to this Report, but excluding Exhibits 99.1 and 99.3 to this Report) shall be deemed to be filed with the Securities and Exchange Commission and is hereby incorporated by reference into the Company’s registration statements on Form S-8 (File No. 333-273105) and Form F-3 (File No. 333-287332), and any related prospectuses, as such registration statements and prospectuses may be amended from time to time, and to be part thereof from the date on which this Report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBIT INDEX

Exhibit
99.1
Press Release dated November 11, 2026
99.2
Consolidated Financial Statements and the Management’s Discussion and Analysis for the three and nine months ended September 30, 2026
99.3
Presentation dated November 11, 2026




Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


PELAGOS INSURANCE CAPITAL LIMITED
Dated: November 12, 2026
By:
/s/ Allan C. Decleir
Name:
Allan C. Decleir
Title:
Group Chief Financial Officer
                            
    
    

pelagosiclogobluergba.jpg





Pelagos Insurance Capital Reports Third Quarter 2026 Results
Gross premiums written of $839.8 million, growth of 5.3% from the third quarter of 2025
Annualized Operating ROAE of 15.3%
Third Quarter 2026 Highlights:
•Gross premiums written of $839.8 million; growth of 5.3% from the third quarter of 2025
•Combined ratio of 91.5%
•Annualized operating return on average common equity (“Annualized Operating ROAE”) of 15.3%
•Total capital returned to common shareholders in the quarter of $95.2 million, including common share repurchases of $83.0 million, at an average price of $24.55 per share, and dividends of $12.2 million
•Net income of $61.7 million, or $0.74 per diluted common share, and operating net income of $83.3 million, or $1.00 per diluted common share
Nine Months Ended September 30, 2026 Highlights:
•Gross premiums written of $4.0 billion; growth of 6.4% from the first nine months of 2025
•Combined ratio of 92.4%, an improvement of 7 points compared to 99.5% in the first nine months of 2025
•Annualized Operating ROAE of 11.8%, an improvement of 7 points compared to the first nine months of 2025
•Total capital returned to common shareholders was $400.5 million, including common share repurchases of $362.5 million, at an average price of $20.47 per share, and dividends of $38.0 million
•Net income of $214.1 million, or $2.46 per diluted common share, and operating net income of $200.4 million, or $2.30 per diluted common share
•Book value per diluted common share was $26.60 at September 30, 2026, an increase of 8.1% from December 31, 2025, of $24.61. This was impacted by the mark-to-market due to higher interest rates. Excluding accumulated other comprehensive income/(loss) (“AOCI”), book value per diluted common share increased 11.9% to $27.11 from $24.23 at December 31, 2025
Pembroke, Bermuda, November 11, 2026 - Pelagos Insurance Capital Limited (“Pelagos” or “PLGO” or the “Company”) (NYSE: PLGO) announced today its financial results for the third quarter ended September 30, 2026.
Dan Burrows, Group Chief Executive Officer of Pelagos Insurance Capital, commented: “We delivered a strong quarter with 15.3% annualized operating ROAE. These results demonstrate the strength of our capital allocator strategy and our ability to respond to changing market conditions, access a broader range of opportunities, and deploy capital to the most attractive areas of the market. Our advantage is simple: no single underwriting team sees every opportunity. By partnering with multiple leading teams, we expand our opportunity set and create a stronger, more diversified portfolio.
“Looking ahead, we see significant opportunity to build on the momentum across our expanding underwriting partner network. Combined with our strong balance sheet and the ability to pursue both profitable growth and accretive capital management, we are well positioned to accelerate top-line growth, generate attractive risk-adjusted returns, and create long-term value for our shareholders."
Pelagos Insurance Capital Limited
Wellesley House South | 90 Pitts Bay Road | HM08 | Pembroke | Bermuda
1


Third Quarter 2026 Consolidated Results
•Net income for the third quarter of 2026 was $61.7 million, or $0.74 per diluted common share. Operating net income was $83.3 million, or $1.00 per diluted common share.
•Underwriting income for the third quarter of 2026 was $67.0 million and the combined ratio was 91.5%, compared to underwriting income of $125.5 million and a combined ratio of 79.0% in the third quarter of 2025.
•Net adverse prior year loss reserve development for the third quarter of 2026 was $4.7 million, compared to net favorable development of $16.0 million in the prior year period.
•Catastrophe and large losses for the third quarter of 2026 were $115.9 million compared to $57.4 million in the prior year period.
•Net investment income for the third quarter of 2026 was $44.6 million compared to $45.9 million in the prior year period.
•Net realized and unrealized investment losses for the third quarter of 2026 were $27.4 million, which included $9.0 million of net realized and unrealized losses on other investments.
•Annualized Operating ROAE of 15.3% in the quarter compared to 21.4% in the prior year period.
Nine Months Ended September 30, 2026 Consolidated Results
•Net income for the nine months ended September 30, 2026, was $214.1 million, or $2.46 per diluted common share. Operating net income was $200.4 million, or $2.30 per diluted common share.
•Underwriting income for the nine months ended September 30, 2026, was $146.0 million and the combined ratio was 92.4%, compared to underwriting income of $10.4 million and a combined ratio of 99.5% for the nine months ended September 30, 2025.
•Catastrophe and large losses for the nine months ended September 30, 2026, were $350.0 million compared to $465.0 million in the prior year period.
•Net favorable prior year loss reserve development of $31.1 million compared to net adverse development of $32.4 million in the prior year period.
•Net investment income of $132.3 million compared to $140.0 million in the prior year period.
•Net realized and unrealized investment losses for the nine months ended September 30, 2026 were $4.1 million, which included $17.9 million of net realized and unrealized gains on other investments. This compared to net realized and unrealized investment gains for the nine months ended September 30, 2025 of $18.8 million, which included $10.4 million of net realized and unrealized gains on other investments.
•Annualized Operating ROAE of 11.8% for the nine months ended September 30, 2026, compared to 5.2% in the prior year period.
•Book value per diluted common share was $26.60 at September 30, 2026 (dilutive shares at September 30, 2026 of 1,164,367), compared to $24.61 at December 31, 2025. This was impacted by the mark-to-market due to higher interest rates. Excluding accumulated other comprehensive income/(loss) (“AOCI”), book value per diluted common share increased 11.9% to $27.11 from $24.23 at December 31, 2025.

2



The following table details key financial indicators in evaluating our performance for the three and nine months ended September 30, 2026 and 2025:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
($ in millions, except per share data)
Net income$61.7 $130.5 $214.1 $107.7 
Operating net income(1)
83.3 126.8 200.4 95.2 
Gross premiums written839.8 797.5 3,977.0 3,739.4 
Net premiums earned783.7 599.8 1,933.3 1,740.8 
Catastrophe and large losses115.9 57.4 350.0 465.0 
Net favorable/(adverse) prior year reserve development(4.7)16.0 31.1 (32.4)
Net investment income44.6 45.9 132.3 140.0 
Net realized and unrealized investment gains/(losses)$(27.4)$6.2 $(4.1)$18.8 
Combined ratio91.5%79.0%92.4%99.5%
Annualized Operating ROAE(1)
15.3%21.4%11.8 %5.2%
Earnings per diluted common share$0.74 $1.24 $2.46 $0.99 
Operating EPS(1)
$1.00 $1.21 $2.30 $0.88 
________________
(1) See definition and reconciliation in “Non-GAAP Financial Measures Reconciliation”
Segment Results
Insurance Segment
The following table is a summary of our Insurance segment’s underwriting results:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
($ in millions)
Gross premiums written$686.1 $605.8 $80.3 $3,035.7 $2,775.1 $260.6 
Reinsurance premium ceded(165.6)(217.3)51.7 (967.7)(1,031.5)63.8 
Net premiums written520.5 388.5 132.0 2,068.0 1,743.6 324.4 
Net premiums earned634.0 456.5 177.5 1,663.6 1,427.3 236.3 
Losses and loss adjustment expenses(341.6)(177.0)(164.6)(870.6)(750.2)(120.4)
Policy acquisition expenses(193.8)(137.2)(56.6)(496.9)(434.3)(62.6)
Underwriting income$98.6 $142.3 $(43.7)$296.1 $242.8 $53.3 
Loss ratio53.9 %38.8 %15.1 pts52.3 %52.6 %(0.3) pts
Policy acquisition expense ratio30.6 %30.1 %0.5 pts29.9 %30.4 %(0.5) pts
Underwriting ratio84.5 %68.9 %15.6 pts82.2 %83.0 %(0.8) pts
For the three months ended September 30, 2026, our GPW increased primarily driven by growth from our Other Insurance and Marine lines of business. For the nine months ended September 30, 2026, our GPW increased primarily driven by growth from our network of expanded underwriting partners, in several lines of business, partially offset by a non-renewal in our Cyber line of business that did not meet our underwriting criteria and rating hurdles.
For the three and nine months ended September 30, 2026, net premiums earned ("NPE") increased due to earnings from higher net premiums written in the current and prior year periods, and as a result of higher gross premiums written in our Marine line of business.
Our policy acquisition expense ratio for the three and nine months ended September 30, 2026 remained consistent with the prior year periods.
3



The following table is a summary of our Insurance segment’s losses and loss adjustment expenses:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
($ in millions)
Attritional losses$206.6 $121.5 $85.1 $512.3 $365.3 $147.0 
Catastrophe and large losses119.2 58.2 61.0 348.0 281.7 66.3 
(Favorable)/adverse prior year development15.8 (2.7)18.5 10.3 103.2 (92.9)
Losses and loss adjustment expenses$341.6 $177.0 $164.6 $870.6 $750.2 $120.4 
Loss ratio - attritional losses32.6 %26.6 %6.0 pts30.8 %25.6 %5.2 pts
Loss ratio - catastrophe and large losses18.8 %12.8 %6.0 pts20.9 %19.8 %1.1 pts
Loss ratio - prior accident years2.5 %(0.6)%3.1 pts0.6 %7.2 %(6.6) pts
Loss ratio53.9 %38.8 %15.1 pts52.3 %52.6 %(0.3) pts
For the three months ended September 30, 2026, our loss ratio in the Insurance segment increased by 15.1 points compared to the prior year period. For the nine months ended September 30, 2026, our loss ratio in the Insurance segment improved by 0.3 points compared to the prior year period.
The attritional loss ratio for the three and nine months ended September 30, 2026, increased by 6.0 points and 5.2 points, respectively, compared to the prior year periods due to the prior year periods being benign in terms of attritional losses.
The catastrophe and large losses for the three months ended September 30, 2026, were primarily attributable to losses related to the conflicts in the Black Sea and the Middle East in our Marine line of business. This compared to the prior period catastrophe and large losses that were primarily attributable to two loss events in our Property and Other Insurance lines of business. The catastrophe and large losses for the nine months ended September 30, 2026 were primarily attributable to losses related to the conflicts in the Middle East and the Black Sea, the gas plant explosion at the Ras Laffan facility in Qatar, as well as loss events in various lines of business including Other Insurance, Property and Marine. This compared to the prior period catastrophe and large losses that were primarily attributable to the California wildfires in our Property line of business, together with other losses in our Other Insurance, Aviation & Aerospace, and Property lines of business.
For the three months ended September 30, 2026, adverse prior year development was primarily driven by our Political Risk, Violence and Terror line of business, partially offset by better than expected loss emergence in multiple lines of business. For the nine months ended September 30, 2026, adverse prior year development was primarily driven by increased loss estimates related to the Baltimore Bridge collapse within our Marine line of business, as well as increased loss estimates in our Political Risk, Violence and Terror line of business and increases in prior year property D&F losses. These increases were partially offset by better than expected loss emergence in multiple lines of business.
4



Reinsurance Segment
The following table is a summary of our Reinsurance segment’s underwriting results:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
($ in millions)
Gross premiums written$153.7 $191.7 $(38.0)$941.3 $964.3 $(23.0)
Reinsurance premium ceded(81.9)(76.0)(5.9)(467.5)(478.4)10.9 
Net premiums written71.8 115.7 (43.9)473.8 485.9 (12.1)
Net premiums earned149.7 143.3 6.4 269.7 313.5 (43.8)
Losses and loss adjustment expenses(10.3)(3.7)(6.6)2.3 (156.4)158.7 
Policy acquisition expenses(44.7)(42.1)(2.6)(80.0)(81.9)1.9 
Underwriting income$94.7 $97.5 $(2.8)$192.0 $75.2 $116.8 
Loss ratio6.9 %2.6 %4.3 pts(0.9)%49.9 %(50.8) pts
Policy acquisition expense ratio29.9 %29.4 %0.5 pts29.7 %26.1 %3.6 pts
Underwriting ratio36.8 %32.0 %4.8 pts28.8 %76.0 %(47.2) pts
For the three months ended September 30, 2026, GPW decreased compared to the prior year period, primarily due to the restructuring of a client's program. For the nine months ended September 30, 2026, our GPW decreased primarily from reinstatement premiums related to the California wildfires in the prior year period and the restructuring of a client's program. The decrease was partially offset by targeted deployment into areas where we continue to see attractive risk-adjusted returns.
For the three months ended September 30, 2026, NPE increased driven by our expanded network of underwriting partners and business mix. For the nine months ended September 30, 2026, NPE decreased due to the acceleration of earnings on contracts with exposure to the California wildfires in the prior year period and changes in our business mix.
Our policy acquisition expense ratio for the three and nine months ended September 30, 2026 increased primarily due to business mix and changes in ceded premium and commissions earned from outwards reinsurance partners.
The following table is a summary of our Reinsurance segment’s losses and loss adjustment expenses:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
($ in millions)
Attritional losses$24.7 $17.8 $6.9 $37.1 $43.9 $(6.8)
Catastrophe and large losses(3.3)(0.8)(2.5)2.0 183.3 (181.3)
Favorable prior year development(11.1)(13.3)2.2 (41.4)(70.8)29.4 
Losses and loss adjustment expenses$10.3 $3.7 $6.6 $(2.3)$156.4 $(158.7)
Loss ratio - attritional losses16.5 %12.5 %4.0 pts13.8 %14.0 %(0.2) pts
Loss ratio - catastrophe and large losses(2.2)%(0.6)%(1.6) pts0.7 %58.5 %(57.8) pts
Loss ratio - prior accident years(7.4)%(9.3)%1.9 pts(15.4)%(22.6)%7.2 pts
Loss ratio6.9 %2.6 %4.3 pts(0.9)%49.9 %(50.8) pts
For the three months ended September 30, 2026, our loss ratio in the Reinsurance segment increased by 4.3 points compared to the prior year period. For the nine months ended September 30, 2026, our loss ratio in the Reinsurance segment improved by 50.8 points compared to the prior year period.
The attritional loss ratio for the three months ended September 30, 2026, increased by 4.0 points compared to the prior year period, both of which were benign in terms of attritional losses. The attritional loss ratio for the nine months ended September 30, 2026, remained consistent with the prior year period.
There were no material catastrophe and large losses for the three and nine months ended September 30, 2026. There were no material catastrophe and large losses for the three months ended September 30, 2025. The catastrophe and large losses for the nine months ended September 30, 2025 were attributable to the California wildfires.
For the three and nine months ended September 30, 2026, favorable prior year development was driven by positive development on catastrophe losses and benign prior year attritional experience.
5



Other Underwriting Expenses
We do not allocate The Fidelis Partnership commissions or general and administrative expenses by segment.
The Fidelis Partnership Commissions
The Fidelis Partnership manages origination, underwriting, underwriting administration, outwards reinsurance and claims handling under delegated authority agreements with the Company. The following table summarizes The Fidelis Partnership commissions earned:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
($ in millions)
Ceding commission expense$89.2 $87.1 $2.1 $244.2 $236.1 $8.1 
Profit commission expense7.6 — 7.6 9.9 — 9.9 
The Fidelis Partnership commissions$96.8 $87.1 $9.7 $254.1 $236.1 $18.0 
Ceding commission expense ratio11.4 %14.5 %(3.1) pts12.6 %13.6 %(1.0) pts
Profit commission expense ratio1.0 %— %1.0 pts0.5 %— %0.5 pts
The Fidelis Partnership commissions ratio12.4 %14.5 %(2.1) pts13.1 %13.6 %(0.5) pts
For the three and nine months ended September 30, 2026, the decrease in The Fidelis Partnership commissions ratio was driven by our business mix, partially offset by the increase of the accrued profit commission as a result of operating profit in the periods.
General and Administrative Expenses
For the three and nine months ended September 30, 2026, general and administrative expenses were $29.5 million and $88.0 million, respectively (2025: $27.2 million and $71.5 million, respectively). The increase was due to strategic investments to strengthen our talent base, enhance our infrastructure and improve our technology. Also, improved financial performance resulted in higher variable compensation accruals in the current year.
Investments
The components of net investment return are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
($ in millions)
Net investment income$44.6 $45.9 $(1.3)$132.3 $140.0 $(7.7)
Net realized and unrealized gains/(losses) on other investments(9.0)4.7 (13.7)17.9 10.4 7.5 
Net realized and unrealized investment gains/(losses) excluding other investments(18.4)1.5 (19.9)(22.0)8.4 (30.4)
Net investment return
$17.2 $52.1 $(34.9)$128.2 $158.8 $(30.6)
Net Investment Income
Net investment income is the interest income earned on our cash balances, available-for-sale (AFS) fixed income securities and distributions received from our fixed income funds and private credit funds, net of total investment expenses.
For the three and nine months ended September 30, 2026, we generated net investment income of $44.6 million and $132.3 million, respectively, at an average annualized yield of 4.6% and 4.3%, respectively (2025: $45.9 million and $140.0 million at an average annualized yield of 4.5% and 4.4%). The decrease in our net investment income for the three months ended September 30, 2026, was driven by lower investable assets compared to the prior year period. For the nine months ended September 30, 2026, the decrease was primarily driven by lower investable assets compared to the prior year period.
6



Net Realized and Unrealized Gains/(Losses) on Other Investments
Net realized and unrealized gains/(losses) on other investments is the change in net asset value ("NAV") of our fixed income fund, hedge fund and private credit fund investments. The decrease for the three months ended September 30, 2026, was driven by a negative change in the NAV on our fixed income funds as interest rates moved higher in the quarter and by a negative performance from our hedge fund portfolio. For the nine months ended September 30, 2026, the increase was driven by positive performance from our hedge fund portfolio, partially offset by a negative change in the NAV on our fixed income funds as interest rates moved higher in the year.
Net Realized and Unrealized Investment Gains/(Losses) Excluding Other Investments
Net realized and unrealized investment gains/(losses) excluding other investments includes net realized gains/(losses) on sales of fixed maturity securities, available-for-sale, and movements in our provision for current expected credit losses.
For the three and nine months ended September 30, 2026, the decrease resulted primarily from movements in our provision for current expected credit losses of $(15.7) million and $(18.7) million, respectively (2025: $0.3 million and $5.6 million).
Other Items
Share Repurchases
In the three and nine months ended September 30, 2026, we repurchased 3,383,048 and 17,707,715 common shares, respectively, for an aggregate of $83.0 million and $362.5 million, respectively, excluding expenses, at an average price of $24.55 and $20.47 per common share, respectively, pursuant to our share repurchase authorization.
Included in common shares repurchased in the three and nine months ended September 30, 2026 were 1,402,800 and 2,842,800 common shares, respectively, from Pine Brook Feal Intermediate, L.P. for an aggregate of $35.0 million and $66.7 million, respectively, through privately negotiated transactions. This resulted in a pro-rata repurchase of 153,709 and 311,494 common shares, respectively, from The Fidelis Partnership for $3.8 million and $7.3 million, respectively.
Included in common shares repurchased for the nine months ended September 30, 2026 were 8,597,170 common shares from CVC Falcon Holdings Limited for an aggregate of $163.3 million through a privately negotiated transaction. This resulted in a pro-rata repurchase of 942,014 common shares from The Fidelis Partnership for $17.9 million.
On November 3, 2026, we announced that our Board of Directors approved the replenishment of our share repurchase authorization, bringing the total current authorization to $400.0 million.
Dividend Announcement
On November 3, 2026, we announced that our Board of Directors approved an increase to the quarterly dividend to $0.22 per common share, declaring the dividend payable on December 23, 2026, to common shareholders of record on December 11, 2026.
Conference Call
Pelagos will host a teleconference to discuss its financial results on Thursday, November 12, 2026, at 9:00 a.m. Eastern time. The call can be accessed by dialing 1-833-470-1428 (U.S. callers), or 1-646-844-6383 (international callers), and entering the passcode 187208 approximately 10 minutes in advance of the call. A live, listen-only webcast of the call will also be available via the Investors section of the Company’s website at www.pelagosinsurancecapital.com. A recording of the webcast will be available in the Investor Relations section of the Company’s website approximately two hours after the event concludes and will be archived on the site for one year.
About Pelagos Insurance Capital
Pelagos Insurance Capital (NYSE: PLGO), formerly Fidelis Insurance Group (NYSE: FIHL), is an expert capital allocator and risk selector in specialty insurance and reinsurance. We bring together strategic capital and specialist underwriting expertise to deliver value through the cycle.
With a differentiated, diversified portfolio and strong balance sheet, we deploy capital into the most compelling areas of the market through our network of best-in-class underwriting partners. Our deep expertise and multiple points of access to the market enable us to adapt as the market evolves, optimize performance, and produce superior outcomes for clients, brokers, and shareholders.
7



Pelagos Insurance Capital makes the connections that matter in specialty risk.
For additional information about Pelagos Insurance Capital, our people, products and our insurer financial strength ratings please visit our website at www.pelagosinsurancecapital.com.
Non-GAAP Financial Measures
This press release includes, and the related conference call will include, certain financial measures that are not calculated in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) including Operating net income, Operating EPS and Operating ROAE, attritional loss ratio, catastrophe and large loss ratio and book value per diluted common share, excluding accumulated other comprehensive income/(loss), and therefore are non-GAAP financial measures. Reconciliations of such measures to the most comparable U.S. GAAP figures are included in the attached financial information in accordance with Regulation G.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements” which include all statements that do not relate solely to historical or current facts and which may concern our strategy, plans, targets, projections or intentions and are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “continue,” “grow,” “opportunity,” “create,” “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “target,” “tracking,” “expect,” “evolve,” “achieve,” “remain,” “proactive,” “pursue,” “optimize,” “emerge,” “drive,” “enable,” “allow,” “build,” “looking ahead,” “commit,” “strategy,” “predict,” “potential,” “assumption,” “future,” “likely,” “may,” “should,” “could,” “will,” “position” and the negative of these and also similar terms and phrases. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are qualified by these cautionary statements, because they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, targets, projections, anticipated events and trends, the economy and other future conditions, but are subject to significant business, economic, legal and competitive uncertainties, many of which are beyond our control or are subject to change. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.
Forward-looking statements contained therein may include, among others, statements in relation to: targeted operating results such as return on equity, net income and earnings per share, underwriting profitability and target combined, loss and expense ratios, growth in gross premiums written and book value per share; our expectations regarding current settlement discussions, court cases and current settlement and litigation strategies; our expectations regarding our business, including the industries we operate in, and capital management strategy and the performance of our business; information regarding our estimates for catastrophes, claims and other loss events; our expectations regarding our partnerships and strategic agreements, including The Fidelis Partnership; anticipated market conditions, pricing cycles, and competitive positioning; sustainability and renewable energy initiatives; use of and exposure to emerging technologies; our management team and human capital; our share price performance and valuation; and our regulatory or listing status; our liquidity and capital resources; and expectations of the effect on our results of operations and financial condition of our loss claims, litigation, climate change impacts, contingent liabilities and governmental and regulatory investigations and proceedings.
Our actual results in the future could differ materially from those anticipated in any forward-looking statements as a result of changes in assumptions, risks, uncertainties and other factors impacting us, many of which are outside our control, including:
•the inherent uncertainty, volatility and unpredictability of underwriting insurance and reinsurance risks, including low-frequency, high-severity events and natural and non-natural catastrophic events;
•the frequency and severity of claims and loss activity, including the impact of climate change, inflation (including social inflation), emerging claims trends and complex causation or coverage issues;
•limitations in available data and the reliability of pricing, accumulation, catastrophe and other analytical models used to estimate losses and exposures;
•the adequacy of our loss reserves and the actual development of losses and loss adjustment expenses;
•our ability to manage risks associated with macroeconomic, geopolitical and market conditions, sanctions and other global developments, including escalation of tensions in Ukraine (including the Black Sea), or the Middle East;
8



•cyclical changes in the insurance and reinsurance industry, including premium rate movements, competitive pressures and consolidation;
•our ability to implement our strategy, identify and execute growth opportunities and compete effectively;
•any downgrades, potential downgrades or other negative actions by rating agencies;
•the availability, affordability and collectability of reinsurance and retrocessional protections;
•litigation, arbitration and regulatory proceedings and the inherent uncertainty of their outcomes;
•our reliance on TFP and other third parties for underwriting, claims handling and other services, and the effectiveness of our risk management and oversight framework;
•operational risks, including system failures, cybersecurity incidents, data protection breaches and risks associated with emerging technologies, including artificial intelligence, and evolving regulatory requirements applicable thereto;
•risks relating to our investment portfolio, including market volatility, interest rate movements, credit risk, liquidity risk and currency fluctuations;
•our ability to access capital and liquidity, including through letters of credit and other financing arrangements, and our status as a holding company dependent on dividends and other distributions from our operating subsidiaries;
•regulatory developments, including changes in capital regimes, increased supervisory scrutiny and compliance with economic and trade sanctions, anti-bribery and similar laws;
•tax developments, including changes in tax laws, interpretations and international tax initiatives;
•our ability to attract and retain key personnel;
•our potential inability to pay dividends or distributions in accordance with our dividend policy;
•our ability to maintain the listing of our common shares on the NYSE or another national securities exchange;
•the Company’s status as a foreign private issuer; and
•the other risks, uncertainties and other factors disclosed under the section titled ‘Risk Factors’ in our Annual Report on Form 20-F filed with the SEC on March 5, 2026, as well as subsequent current reports and other filings with the SEC available electronically at www.sec.gov.
The foregoing factors should not be construed as exhaustive and should be read together with the other cautionary statements included in our filings with the SEC. All forward-looking statements included herein are expressly qualified in their entirety by the cautionary statements contained or referred to therein. The forward-looking statements contained herein are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond our control and which could cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements, expectations, beliefs and projections made by us in this press release speak only as of the date referenced on such date on which they are made and are expressed in good faith and our management believes that there is reasonable basis for them, based only on information currently available to us. There can be no assurance that management’s expectations, beliefs, and projections will be achieved and actual results may vary materially from what is expressed or indicated by the forward-looking statements. Furthermore, our past performance, and that of our management team and of TFP, should not be construed as a guarantee of future performance. Except to the extent required by applicable laws and regulations, we undertake no obligation to update or revise any forward-looking statements contained in the above discussion, whether as a result of new information, future developments or otherwise. In light of these risks and uncertainties, you should keep in mind that any event described in a forward-looking statement might not occur.

9



Pelagos Insurance Capital Investor Contact:
Pelagos Insurance Capital
Miranda Hunter
+1 (441) 279 2561
Pelagos Insurance Capital Media Contact:
Rein4ce
Stephen Breen
+44 (0) 7843 076556
10



PELAGOS INSURANCE CAPITAL LIMITED
Consolidated Balance Sheets
At September 30, 2026 (Unaudited) and December 31, 2025
(Expressed in millions of U.S. dollars, except for share and per share amounts)
September 30,
2026
December 31, 2025
Assets
Fixed maturity securities, available-for-sale, at fair value
(amortized cost: $2,839.1, 2025: $2,590.6 (net of allowance for credit losses of $19.3, 2025: $0.6))
$2,792.7 $2,640.4 
Short-term investments, available-for-sale, at fair value
(amortized cost: $269.1, 2025: $111.3 (net of allowance for credit losses of $nil, 2025: $nil))
268.7 111.3 
Other investments, at fair value 661.5 485.7 
Total investments3,722.9 3,237.4 
Cash and cash equivalents446.1 873.0 
Restricted cash and cash equivalents80.2 374.6 
Accrued investment income24.9 28.3 
Premiums and other receivables (net of allowance for credit losses of $14.9, 2025: $15.8)
4,038.1 3,322.2 
Amounts due from The Fidelis Partnership (net of allowance for credit losses of $nil, 2025: $nil)
320.4 174.8 
Deferred reinsurance premiums1,604.7 1,441.5 
Reinsurance balances recoverable on paid losses
(net of allowance for credit losses of $0.3, 2025: $0.3)
366.0 438.7 
Reinsurance balances recoverable on reserves for losses and loss adjustment expenses
(net of allowance for credit losses of $0.9, 2025: $0.9)
1,312.4 1,195.6 
Deferred policy acquisition costs
(includes The Fidelis Partnership deferred commissions of $279.6, 2025: $243.4)
1,329.5 1,085.0 
Other assets170.2 272.7 
Total assets$13,415.4 $12,443.8 
Liabilities and shareholders' equity
Liabilities
Reserves for losses and loss adjustment expenses$2,930.6 $2,607.1 
Unearned premiums5,153.9 4,384.8 
Reinsurance balances payable1,702.7 1,659.6 
Amounts due to The Fidelis Partnership 641.9 457.7 
Long term debt720.8 843.2 
Other liabilities124.3 91.8 
Total liabilities11,274.2 10,044.2 
Commitments and contingencies
Shareholders' equity
Common shares ($0.01 par, issued and outstanding: 79,345,285, 2025: 96,651,534)0.8 1.0 
Additional paid-in capital1,330.4 1,685.6 
Accumulated other comprehensive income/(loss)(41.6)37.1 
Retained earnings851.6 675.9 
Total shareholders' equity2,141.2 2,399.6 
Total liabilities and shareholders' equity$13,415.4 $12,443.8 
11



PELAGOS INSURANCE CAPITAL LIMITED
Consolidated Statements of Income and Comprehensive Income (Unaudited)
For the three and nine months ended September 30, 2026 and September 30, 2025
(Expressed in millions of U.S. dollars, except for share and per share amounts)
Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Revenues
Gross premiums written$839.8 $797.5 $3,977.0 $3,739.4 
Reinsurance premiums ceded(247.5)(293.3)(1,435.2)(1,509.9)
Net premiums written592.3 504.2 2,541.8 2,229.5 
Change in net unearned premiums191.4 95.6 (608.5)(488.7)
Net premiums earned783.7 599.8 1,933.3 1,740.8 
Net investment income44.6 45.9 132.3 140.0 
Net realized and unrealized investment gains/(losses)(27.4)6.2 (4.1)18.8 
Total revenues800.9 651.9 2,061.5 1,899.6 
Expenses
Losses and loss adjustment expenses351.9 180.7 868.3 906.6 
Policy acquisition expenses (includes The Fidelis Partnership commissions of $96.8 and $254.1 (2025: $87.1 and $236.1))335.3 266.4 831.0 752.3 
General and administrative expenses29.5 27.2 88.0 71.5 
Corporate and other expenses0.3 — 3.0 1.2 
Net foreign exchange (gains)/losses(2.0)1.7 2.0 2.2 
Financing costs12.5 15.1 39.8 33.1 
Total expenses727.5 491.1 1,832.1 1,766.9 
Income before income taxes73.4 160.8 229.4 132.7 
Income tax expense(11.7)(30.3)(15.3)(25.0)
Net income$61.7 $130.5 $214.1 $107.7 
Other comprehensive income/(loss)
Unrealized gains/(losses) on available-for-sale investments$(62.6)$10.5 $(100.1)$47.1 
Reclassification of net realized losses/(gains) recognized in net income2.7 (1.3)3.4 (2.9)
Income tax (expense)/benefit, all of which relates to unrealized gains/(losses) on available-for-sale investments11.0 (1.8)18.0 (8.6)
Total other comprehensive income/(loss)(48.9)7.4 (78.7)35.6 
Comprehensive income$12.8 $137.9 $135.4 $143.3 
Per share data
Earnings per common share
Earnings per common share$0.75 $1.25 $2.48 $1.00 
Earnings per diluted common share$0.74 $1.24 $2.46 $0.99 
Weighted average common shares outstanding81,899,656 104,370,380 86,384,660 108,156,265 
Weighted average diluted common shares outstanding83,022,195 105,006,130 87,162,021 108,635,908 
12



PELAGOS INSURANCE CAPITAL LIMITED
Consolidated Segment Data (Unaudited)
For the three and nine months ended September 30, 2026 and September 30, 2025
(Expressed in millions of U.S. dollars)
Three Months Ended September 30, 2026
InsuranceReinsuranceOtherTotal
Gross premiums written$686.1 $153.7 $— $839.8 
Net premiums written520.5 71.8 — 592.3 
Net premiums earned634.0 149.7 — 783.7 
Losses and loss adjustment expenses(341.6)(10.3)— (351.9)
Policy acquisition expenses(193.8)(44.7)(96.8)(335.3)
General and administrative expenses— — (29.5)(29.5)
Underwriting income98.6 94.7 67.0 
Net investment income44.6 
Net realized and unrealized investment losses(27.4)
Corporate and other expenses(0.3)
Net foreign exchange gains2.0 
Financing costs(12.5)
Income before income taxes73.4 
Income tax expense(11.7)
Net income$61.7 
Losses and loss adjustment expenses incurred - current year(325.8)(21.4)$(347.2)
Losses and loss adjustment expenses incurred - prior accident years(15.8)11.1 (4.7)
Losses and loss adjustment expenses incurred - total$(341.6)$(10.3)$(351.9)
Underwriting Ratios(1)
Loss ratio - current year51.4%14.3%44.3%
Loss ratio - prior accident years2.5%(7.4%)0.6%
Loss ratio - total53.9%6.9%44.9%
Policy acquisition expense ratio30.6%29.9%30.4%
Underwriting ratio84.5%36.8%75.3%
The Fidelis Partnership commissions ratio12.4%
General and administrative expense ratio3.8%
Combined ratio91.5%
________________
(1)Underwriting ratios are calculated by dividing the related expense by net premiums earned.
13



Three Months Ended September 30, 2025
InsuranceReinsuranceOtherTotal
Gross premiums written$605.8 $191.7 $— $797.5 
Net premiums written388.5 115.7 — 504.2 
Net premiums earned456.5 143.3 — 599.8 
Losses and loss adjustment expenses(177.0)(3.7)— (180.7)
Policy acquisition expenses(137.2)(42.1)(87.1)(266.4)
General and administrative expenses— — (27.2)(27.2)
Underwriting income142.3 97.5 125.5 
Net investment income45.9 
Net realized and unrealized investment gains6.2 
Net foreign exchange losses(1.7)
Financing costs(15.1)
Income before income taxes160.8 
Income tax expense(30.3)
Net income$130.5 
Losses and loss adjustment expenses incurred - current year(179.7)(17.0)$(196.7)
Losses and loss adjustment expenses incurred - prior accident years2.7 13.3 16.0 
Losses and loss adjustment expenses incurred - total$(177.0)$(3.7)$(180.7)
Underwriting Ratios(1)
Loss ratio - current year39.4%11.9%32.8%
Loss ratio - prior accident years(0.6%)(9.3%)(2.7%)
Loss ratio - total38.8%2.6%30.1%
Policy acquisition expense ratio30.1%29.4%29.9%
Underwriting ratio68.9%32.0%60.0%
The Fidelis Partnership commissions ratio14.5%
General and administrative expense ratio4.5%
Combined ratio79.0%
________________
(1)Underwriting ratios are calculated by dividing the related expense by net premiums earned.
14



Nine months ended September 30, 2026
InsuranceReinsuranceOtherTotal
Gross premiums written$3,035.7 $941.3 $— $3,977.0 
Net premiums written2,068.0 473.8 — 2,541.8 
Net premiums earned1,663.6 269.7 — 1,933.3 
Losses and loss adjustment expenses(870.6)2.3 — (868.3)
Policy acquisition expenses(496.9)(80.0)(254.1)(831.0)
General and administrative expenses— — (88.0)(88.0)
Underwriting income296.1 192.0 146.0 
Net investment income132.3 
Net realized and unrealized investment losses(4.1)
Corporate and other expenses(3.0)
Net foreign exchange losses(2.0)
Financing costs(39.8)
Income before income taxes229.4 
Income tax expense(15.3)
Net income$214.1 
Losses and loss adjustment expenses incurred - current year(860.3)(39.1)$(899.4)
Losses and loss adjustment expenses incurred - prior accident years(10.3)41.4 31.1 
Losses and loss adjustment expenses incurred - total$(870.6)$2.3 $(868.3)
Underwriting Ratios(1)
Loss ratio - current year51.7%14.5%46.5%
Loss ratio - prior accident years0.6%(15.4%)(1.6%)
Loss ratio - total52.3%(0.9%)44.9%
Policy acquisition expense ratio29.9%29.7%29.8%
Underwriting ratio82.2%28.8%74.7%
The Fidelis Partnership commissions ratio13.1%
General and administrative expense ratio4.6%
Combined ratio92.4%
________________
(1)Underwriting ratios are calculated by dividing the related expense by net premiums earned.



15



Nine months ended September 30, 2025
InsuranceReinsuranceOtherTotal
Gross premiums written$2,775.1 $964.3 $— $3,739.4 
Net premiums written1,743.6 485.9 — 2,229.5 
Net premiums earned1,427.3 313.5 — 1,740.8 
Losses and loss adjustment expenses(750.2)(156.4)— (906.6)
Policy acquisition expenses(434.3)(81.9)(236.1)(752.3)
General and administrative expenses— — (71.5)(71.5)
Underwriting income242.8 75.2 10.4 
Net investment income140.0 
Net realized and unrealized investment gains18.8 
Corporate and other expenses(1.2)
Net foreign exchange losses(2.2)
Financing costs(33.1)
Income before income taxes132.7 
Income tax expense(25.0)
Net income$107.7 
Losses and loss adjustment expenses incurred - current year(647.0)(227.2)$(874.2)
Losses and loss adjustment expenses incurred - prior accident years(103.2)70.8 (32.4)
Losses and loss adjustment expenses incurred - total$(750.2)$(156.4)$(906.6)
Underwriting Ratios(1)
Loss ratio - current year45.4%72.5%50.2%
Loss ratio - prior accident years7.2%(22.6%)1.9%
Loss ratio - total52.6%49.9%52.1%
Policy acquisition expense ratio30.4%26.1%29.7%
Underwriting ratio83.0%76.0%81.8%
The Fidelis Partnership commissions ratio13.6%
General and administrative expense ratio4.1%
Combined ratio99.5%
________________
(1)Underwriting ratios are calculated by dividing the related expense by net premiums earned.




16



PELAGOS INSURANCE CAPITAL LIMITED
NON-GAAP FINANCIAL MEASURES RECONCILIATION (UNAUDITED)
Attritional loss ratio and catastrophe and large loss ratio: the attritional loss ratio is a non-GAAP measure of the loss ratio excluding the impact of catastrophe and large losses. Management believes that the attritional loss ratio is a performance measure that is useful to investors as it excludes losses that are not as predictable as to timing and amount. The attritional loss ratio is calculated by dividing the losses and loss adjustment expenses, excluding catastrophe and large losses and prior year development, by NPE. The catastrophe and large loss ratio is a non-GAAP measure that is calculated by dividing the current year catastrophe and large loss expense by NPE. The reconciliation of these non-GAAP measures is included in each segment’s summary of losses and loss adjustment expenses table.

Operating net income: is a non-GAAP financial measure of our performance which does not consider the impact of certain non-recurring and other items that may not properly reflect the ordinary activities of our business, its performance or its future outlook. This measure is calculated as net income excluding net realized and unrealized investment gains/(losses), net foreign exchange gains/(losses), corporate and other expenses, and the income tax effect on these items.
Annualized return on average common equity (“Annualized ROAE”): represents annualized net income divided by average common shareholders’ equity.
Annualized operating return on average common equity (“Annualized Operating ROAE”): is a non-GAAP financial measure that represents a meaningful comparison between periods of our financial performance expressed as a percentage and is calculated as annualized operating net income divided by average common shareholders’ equity.
Operating earnings per share (“Operating EPS”): is a non-GAAP financial measure that represents a valuable measure of profitability and enables investors, analysts, rating agencies and other users of our financial information to more easily analyze our results in a manner similar to how management analyzes its underlying business performance. It is calculated by dividing operating net income by the weighted average diluted common shares outstanding.
The table below sets out the calculation of our Operating net income, Annualized ROAE, Annualized Operating ROAE and Operating EPS, for the three and nine months ended September 30, 2026, and 2025.
Three months endedNine months ended
($ in millions except for share and per share amounts)September 30,
2026
September 30, 2025September 30,
2026
September 30, 2025
Net income$61.7 $130.5 $214.1 $107.7 
Adjustment for net realized and unrealized investment (gains)/losses27.4 (6.2)4.1 (18.8)
Adjustment for net foreign exchange (gains)/losses(2.0)1.7 2.0 2.2 
Adjustment for corporate and other expenses0.3 — 3.0 1.2 
Income tax (benefit)/expense (1)
(4.1)0.8 (22.8)2.9 
Operating net income$83.3 $126.8 $200.4 $95.2 
Average common shareholders' equity$2,180.9 $2,369.8 $2,270.4 $2,432.3 
Weighted average common shares outstanding81,899,656 104,370,380 86,384,660 108,156,265 
Share-based compensation plans1,122,539 635,750 777,361 479,643 
Weighted average diluted common shares outstanding83,022,195 105,006,130 87,162,021 108,635,908 
Annualized ROAE11.3%22.0%12.6%5.9%
Annualized Operating ROAE15.3%21.4%11.8%5.2%
Earnings per diluted common share$0.74 $1.24 $2.46 $0.99 
Operating EPS$1.00 $1.21 $2.30 $0.88 
(1) Income tax (benefit)/expense on adjustments to net income/(loss). The income tax benefit for the nine months ended September 30, 2026 includes the reversal of a U.K. top-up tax charge of $21.4 million.
17



Book value per diluted common share, excluding accumulated other comprehensive income/(loss) (“AOCI”): is a non-GAAP measure of financial position. We believe this measure provides investors with useful information regarding our book value per diluted common share because it excludes the impact of AOCI, which may vary between periods due to, among other factors, changes in interest rates and credit spreads, and thereby facilitates comparisons of book value across periods. The effect of dilutive restricted share units is calculated using the treasury stock method. A reconciliation of book value per diluted common share, excluding AOCI, to book value per diluted common share, the most directly comparable GAAP financial measure, is presented below.
($ in millions except for share and per share amounts)September 30,
2026
December 31, 2025
Total shareholders' equity $2,141.2 $2,399.6 
Less: Accumulated other comprehensive income/(loss) ("AOCI")41.6 (37.1)
Total shareholders' equity, excluding AOCI2,182.8 2,362.5 
Common shares outstanding79,345,28596,651,534
Effect of dilutive restricted share units1,164,367862,605
Dilutive common shares outstanding80,509,65297,514,139
Book value per diluted common share$26.60 $24.61 
Book value per diluted common share, excluding AOCI$27.11 $24.23 
18

00016366392026Q3FALSESeptember 30, 202612/316-KP1YP3Yiso4217:USDiso4217:USDxbrli:sharesxbrli:sharesxbrli:purefihl:segmentfihl:security00016366392026-01-012026-09-300001636639us-gaap:FixedMaturitiesMember2026-09-300001636639us-gaap:FixedMaturitiesMember2025-12-310001636639us-gaap:ShortTermInvestmentsMember2026-09-300001636639us-gaap:ShortTermInvestmentsMember2025-12-3100016366392026-09-3000016366392025-12-310001636639us-gaap:RelatedPartyMember2026-09-300001636639us-gaap:RelatedPartyMember2025-12-3100016366392026-07-012026-09-3000016366392025-07-012025-09-3000016366392025-01-012025-09-300001636639us-gaap:RelatedPartyMember2026-07-012026-09-300001636639us-gaap:RelatedPartyMember2026-01-012026-09-300001636639us-gaap:RelatedPartyMember2025-07-012025-09-300001636639us-gaap:RelatedPartyMember2025-01-012025-09-300001636639us-gaap:CommonStockMember2026-06-300001636639us-gaap:CommonStockMember2025-06-300001636639us-gaap:CommonStockMember2025-12-310001636639us-gaap:CommonStockMember2024-12-310001636639us-gaap:CommonStockMember2026-07-012026-09-300001636639us-gaap:CommonStockMember2025-07-012025-09-300001636639us-gaap:CommonStockMember2026-01-012026-09-300001636639us-gaap:CommonStockMember2025-01-012025-09-300001636639us-gaap:CommonStockMember2026-09-300001636639us-gaap:CommonStockMember2025-09-300001636639us-gaap:TreasuryStockCommonMember2026-06-300001636639us-gaap:TreasuryStockCommonMember2025-06-300001636639us-gaap:TreasuryStockCommonMember2025-12-310001636639us-gaap:TreasuryStockCommonMember2024-12-310001636639us-gaap:TreasuryStockCommonMember2026-07-012026-09-300001636639us-gaap:TreasuryStockCommonMember2025-07-012025-09-300001636639us-gaap:TreasuryStockCommonMember2026-01-012026-09-300001636639us-gaap:TreasuryStockCommonMember2025-01-012025-09-300001636639us-gaap:TreasuryStockCommonMember2026-09-300001636639us-gaap:TreasuryStockCommonMember2025-09-300001636639us-gaap:AdditionalPaidInCapitalMember2026-06-300001636639us-gaap:AdditionalPaidInCapitalMember2025-06-300001636639us-gaap:AdditionalPaidInCapitalMember2025-12-310001636639us-gaap:AdditionalPaidInCapitalMember2024-12-310001636639us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-300001636639us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300001636639us-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-300001636639us-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300001636639us-gaap:AdditionalPaidInCapitalMember2026-09-300001636639us-gaap:AdditionalPaidInCapitalMember2025-09-300001636639us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2026-06-300001636639us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-06-300001636639us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-12-310001636639us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-12-310001636639us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2026-07-012026-09-300001636639us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-07-012025-09-300001636639us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2026-01-012026-09-300001636639us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-01-012025-09-300001636639us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2026-09-300001636639us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-09-300001636639us-gaap:RetainedEarningsMember2026-06-300001636639us-gaap:RetainedEarningsMember2025-06-300001636639us-gaap:RetainedEarningsMember2025-12-310001636639us-gaap:RetainedEarningsMember2024-12-310001636639us-gaap:RetainedEarningsMember2026-07-012026-09-300001636639us-gaap:RetainedEarningsMember2025-07-012025-09-300001636639us-gaap:RetainedEarningsMember2026-01-012026-09-300001636639us-gaap:RetainedEarningsMember2025-01-012025-09-300001636639us-gaap:RetainedEarningsMember2026-09-300001636639us-gaap:RetainedEarningsMember2025-09-3000016366392025-09-3000016366392024-12-310001636639fihl:Syndicate3123Member2024-05-220001636639fihl:SpecialtyMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300001636639fihl:ReinsuranceMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300001636639us-gaap:CorporateNonSegmentMember2026-07-012026-09-300001636639fihl:SpecialtyMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300001636639fihl:ReinsuranceMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300001636639us-gaap:CorporateNonSegmentMember2025-07-012025-09-300001636639fihl:SpecialtyMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300001636639fihl:ReinsuranceMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300001636639us-gaap:CorporateNonSegmentMember2026-01-012026-09-300001636639fihl:SpecialtyMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300001636639fihl:ReinsuranceMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300001636639us-gaap:CorporateNonSegmentMember2025-01-012025-09-300001636639us-gaap:USTreasurySecuritiesMember2026-09-300001636639us-gaap:ForeignGovernmentDebtSecuritiesMember2026-09-300001636639us-gaap:CorporateDebtSecuritiesMember2026-09-300001636639us-gaap:ResidentialMortgageBackedSecuritiesMember2026-09-300001636639us-gaap:CommercialMortgageBackedSecuritiesMember2026-09-300001636639us-gaap:AssetBackedSecuritiesMember2026-09-300001636639us-gaap:USTreasurySecuritiesMember2025-12-310001636639us-gaap:AgencySecuritiesMember2025-12-310001636639us-gaap:ForeignGovernmentDebtSecuritiesMember2025-12-310001636639us-gaap:CorporateDebtSecuritiesMember2025-12-310001636639us-gaap:ResidentialMortgageBackedSecuritiesMember2025-12-310001636639us-gaap:CommercialMortgageBackedSecuritiesMember2025-12-310001636639us-gaap:AssetBackedSecuritiesMember2025-12-310001636639us-gaap:FixedMaturitiesMemberfihl:AAAMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMemberfihl:AAAMember2026-01-012026-09-300001636639us-gaap:FixedMaturitiesMemberfihl:AAAMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMemberfihl:AAAMember2025-01-012025-12-310001636639us-gaap:FixedMaturitiesMemberfihl:AAMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMemberfihl:AAMember2026-01-012026-09-300001636639us-gaap:FixedMaturitiesMemberfihl:AAMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMemberfihl:AAMember2025-01-012025-12-310001636639us-gaap:FixedMaturitiesMemberfihl:AMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMemberfihl:AMember2026-01-012026-09-300001636639us-gaap:FixedMaturitiesMemberfihl:AMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMemberfihl:AMember2025-01-012025-12-310001636639us-gaap:FixedMaturitiesMemberfihl:BBBMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMemberfihl:BBBMember2026-01-012026-09-300001636639us-gaap:FixedMaturitiesMemberfihl:BBBMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMemberfihl:BBBMember2025-01-012025-12-310001636639us-gaap:FixedMaturitiesMemberfihl:BelowBBBMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMemberfihl:BelowBBBMember2026-01-012026-09-300001636639us-gaap:FixedMaturitiesMemberfihl:BelowBBBMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMemberfihl:BelowBBBMember2025-01-012025-12-310001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMember2026-01-012026-09-300001636639us-gaap:CreditConcentrationRiskMemberus-gaap:FixedMaturitiesMemberfihl:CreditRatingMember2025-01-012025-12-310001636639us-gaap:USTreasurySecuritiesMemberus-gaap:ShortTermInvestmentsMember2026-09-300001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMember2026-09-300001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:ShortTermInvestmentsMember2026-09-300001636639us-gaap:USTreasurySecuritiesMemberus-gaap:ShortTermInvestmentsMember2025-12-310001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMember2025-12-310001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:ShortTermInvestmentsMember2025-12-310001636639us-gaap:ShortTermInvestmentsMemberfihl:AAAMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberus-gaap:ShortTermInvestmentsMemberfihl:CreditRatingMemberfihl:AAAMember2026-01-012026-09-300001636639us-gaap:ShortTermInvestmentsMemberfihl:AAAMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberus-gaap:ShortTermInvestmentsMemberfihl:CreditRatingMemberfihl:AAAMember2025-01-012025-12-310001636639us-gaap:ShortTermInvestmentsMemberfihl:AAMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberus-gaap:ShortTermInvestmentsMemberfihl:CreditRatingMemberfihl:AAMember2026-01-012026-09-300001636639us-gaap:ShortTermInvestmentsMemberfihl:AAMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberus-gaap:ShortTermInvestmentsMemberfihl:CreditRatingMemberfihl:AAMember2025-01-012025-12-310001636639us-gaap:ShortTermInvestmentsMemberfihl:AMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberus-gaap:ShortTermInvestmentsMemberfihl:CreditRatingMemberfihl:AMember2026-01-012026-09-300001636639us-gaap:ShortTermInvestmentsMemberfihl:AMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberus-gaap:ShortTermInvestmentsMemberfihl:CreditRatingMemberfihl:AMember2025-01-012025-12-310001636639us-gaap:ShortTermInvestmentsMemberfihl:BBBMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberus-gaap:ShortTermInvestmentsMemberfihl:CreditRatingMemberfihl:BBBMember2026-01-012026-09-300001636639us-gaap:ShortTermInvestmentsMemberfihl:BBBMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberus-gaap:ShortTermInvestmentsMemberfihl:CreditRatingMemberfihl:BBBMember2025-01-012025-12-310001636639us-gaap:CreditConcentrationRiskMemberus-gaap:ShortTermInvestmentsMemberfihl:CreditRatingMember2026-01-012026-09-300001636639us-gaap:CreditConcentrationRiskMemberus-gaap:ShortTermInvestmentsMemberfihl:CreditRatingMember2025-01-012025-12-3100016366392026-06-3000016366392025-06-300001636639fihl:MultiAssetCreditFundsMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:MultiAssetCreditFundsMember2026-01-012026-09-300001636639fihl:MultiAssetCreditFundsMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:MultiAssetCreditFundsMember2025-01-012025-12-310001636639us-gaap:CreditMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberus-gaap:CreditMember2026-01-012026-09-300001636639us-gaap:CreditMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberus-gaap:CreditMember2025-01-012025-12-310001636639fihl:GlobalMacroMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:GlobalMacroMember2026-01-012026-09-300001636639fihl:GlobalMacroMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:GlobalMacroMember2025-01-012025-12-310001636639fihl:LongShortMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:LongShortMember2026-01-012026-09-300001636639fihl:LongShortMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:LongShortMember2025-01-012025-12-310001636639fihl:MultiStrategyAndEventDrivenMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:MultiStrategyAndEventDrivenMember2026-01-012026-09-300001636639fihl:MultiStrategyAndEventDrivenMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:MultiStrategyAndEventDrivenMember2025-01-012025-12-310001636639fihl:HedgeFundInvestmentsMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:HedgeFundInvestmentsMember2026-01-012026-09-300001636639fihl:HedgeFundInvestmentsMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:HedgeFundInvestmentsMember2025-01-012025-12-310001636639fihl:PrivateCreditFundsMember2026-09-300001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:PrivateCreditFundsMember2026-01-012026-09-300001636639fihl:PrivateCreditFundsMember2025-12-310001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMemberfihl:PrivateCreditFundsMember2025-01-012025-12-310001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMember2026-01-012026-09-300001636639us-gaap:CreditConcentrationRiskMemberfihl:CreditRatingMember2025-01-012025-12-310001636639srt:MinimumMember2026-09-300001636639srt:MinimumMember2025-12-310001636639srt:MaximumMember2026-09-300001636639srt:MaximumMember2025-12-310001636639us-gaap:USTreasurySecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:USTreasurySecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:USTreasurySecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:USTreasurySecuritiesMemberus-gaap:FixedMaturitiesMember2026-09-300001636639us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2026-09-300001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2026-09-300001636639us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2026-09-300001636639us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2026-09-300001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2026-09-300001636639us-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:USTreasurySecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:USTreasurySecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:USTreasurySecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:FairValueInputsLevel1Member2026-09-300001636639us-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:FairValueInputsLevel3Member2026-09-300001636639us-gaap:USTreasurySecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:USTreasurySecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:USTreasurySecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:USTreasurySecuritiesMemberus-gaap:FixedMaturitiesMember2025-12-310001636639us-gaap:AgencySecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:AgencySecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:AgencySecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:AgencySecuritiesMemberus-gaap:FixedMaturitiesMember2025-12-310001636639us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2025-12-310001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:FixedMaturitiesMember2025-12-310001636639us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2025-12-310001636639us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2025-12-310001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:FixedMaturitiesMember2025-12-310001636639us-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:FixedMaturitiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:USTreasurySecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:USTreasurySecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:USTreasurySecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:CorporateDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:AssetBackedSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:FairValueInputsLevel1Member2025-12-310001636639us-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:FairValueInputsLevel3Member2025-12-310001636639us-gaap:SubordinatedDebtMemberfihl:FixedRateResetSubordinatedNotesDue2055Member2025-12-310001636639us-gaap:SubordinatedDebtMemberfihl:FixedRateResetSubordinatedNotesDue2055Member2026-09-300001636639us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SubordinatedDebtMemberfihl:SevenPointSevenFiveZeroSubordinatedNotesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SubordinatedDebtMemberfihl:SevenPointSevenFiveZeroSubordinatedNotesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SubordinatedDebtMemberfihl:SevenPointSevenFiveZeroSubordinatedNotesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SubordinatedDebtMemberfihl:SevenPointSevenFiveZeroSubordinatedNotesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:SeniorNotesMemberfihl:SeniorNotesDue2030Member2025-12-310001636639us-gaap:SeniorNotesMemberfihl:SeniorNotesDue2030Member2026-09-300001636639us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMemberfihl:FourPointEightSevenFivePercentSeniorNotesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMemberfihl:FourPointEightSevenFivePercentSeniorNotesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMemberfihl:FourPointEightSevenFivePercentSeniorNotesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:SeniorNotesMemberfihl:FourPointEightSevenFivePercentSeniorNotesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:JuniorSubordinatedDebtMemberfihl:FixedRateResetJuniorSubordinatedNotesDue2041Member2026-09-300001636639us-gaap:JuniorSubordinatedDebtMemberfihl:FixedRateResetJuniorSubordinatedNotesDue2041Member2025-12-310001636639us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:JuniorSubordinatedDebtMemberfihl:SixPointSixTwoFiveFixedRateResetJuniorSubordinatedNotesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:JuniorSubordinatedDebtMemberfihl:SixPointSixTwoFiveFixedRateResetJuniorSubordinatedNotesMemberus-gaap:FairValueInputsLevel2Member2026-09-300001636639us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:JuniorSubordinatedDebtMemberfihl:SixPointSixTwoFiveFixedRateResetJuniorSubordinatedNotesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:JuniorSubordinatedDebtMemberfihl:SixPointSixTwoFiveFixedRateResetJuniorSubordinatedNotesMemberus-gaap:FairValueInputsLevel2Member2025-12-310001636639us-gaap:FinancialStandbyLetterOfCreditMember2026-09-300001636639us-gaap:FinancialStandbyLetterOfCreditMember2025-12-310001636639fihl:ReinsuranceContractsMember2026-09-300001636639fihl:ReinsuranceContractsMember2025-12-310001636639us-gaap:NondesignatedMemberus-gaap:CreditDefaultSwapMember2026-09-300001636639us-gaap:NondesignatedMemberus-gaap:CreditDefaultSwapMember2025-12-310001636639us-gaap:NondesignatedMemberus-gaap:ForwardContractsMember2026-09-300001636639us-gaap:NondesignatedMemberus-gaap:ForwardContractsMember2025-12-310001636639us-gaap:NondesignatedMember2026-09-300001636639us-gaap:NondesignatedMember2025-12-310001636639us-gaap:CreditDefaultSwapMember2026-07-012026-09-300001636639us-gaap:CreditDefaultSwapMember2025-07-012025-09-300001636639us-gaap:CreditDefaultSwapMember2026-01-012026-09-300001636639us-gaap:CreditDefaultSwapMember2025-01-012025-09-300001636639us-gaap:ForwardContractsMember2026-07-012026-09-300001636639us-gaap:ForwardContractsMember2025-07-012025-09-300001636639us-gaap:ForwardContractsMember2026-01-012026-09-300001636639us-gaap:ForwardContractsMember2025-01-012025-09-300001636639fihl:SpecialtyMember2026-01-012026-09-300001636639fihl:ReinsuranceMember2026-01-012026-09-300001636639fihl:ReinsuranceMember2025-01-012025-09-300001636639fihl:SpecialtyMember2025-01-012025-09-300001636639us-gaap:JuniorSubordinatedDebtMemberfihl:FixedRateResetSubordinatedNotesDue2055Member2025-06-130001636639us-gaap:JuniorSubordinatedDebtMemberfihl:FixedRateResetJuniorSubordinatedNotesDue2041Member2020-10-160001636639us-gaap:JuniorSubordinatedDebtMemberfihl:FixedRateResetJuniorSubordinatedNotesDue2041Member2020-10-200001636639us-gaap:JuniorSubordinatedDebtMemberfihl:FixedRateResetJuniorSubordinatedNotesDue2041Member2026-04-300001636639us-gaap:SeniorNotesMemberfihl:SeniorNotesDue2030Member2020-06-180001636639us-gaap:SeniorNotesMemberfihl:SeniorNotesDue2030Member2020-07-020001636639us-gaap:SeniorNotesMemberfihl:FixedRateResetSubordinatedNotesDue2055Member2026-09-300001636639us-gaap:SeniorNotesMemberfihl:FixedRateResetSubordinatedNotesDue2055Member2025-12-310001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:UnsecuredTrancheMemberfihl:LloydsCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:SecuredTrancheMemberfihl:LloydsCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:LloydsCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:SecuredTrancheMemberfihl:CitibankCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:CitibankCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:UnsecuredTrancheMemberfihl:BarclaysCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:SecuredTrancheMemberfihl:BarclaysCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:BarclaysCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:SecuredTrancheMemberfihl:BankOfMontrealCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:BankOfMontrealCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:UncommittedTrancheMemberfihl:LloydsCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:UncommittedTrancheMemberfihl:CitibankCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMemberfihl:SecuredAccordionMemberfihl:BarclaysCreditAgreementMember2026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMembersrt:MinimumMember2026-01-012026-09-300001636639us-gaap:LineOfCreditMemberus-gaap:StandbyLettersOfCreditMembersrt:MaximumMember2026-01-012026-09-300001636639fihl:FrameworkAgreementMemberfihl:FidelisMGUMemberfihl:GroupMemberus-gaap:RelatedPartyMember2023-01-030001636639fihl:FrameworkAgreementMemberus-gaap:RelatedPartyMember2022-12-202022-12-200001636639fihl:FrameworkAgreementMemberus-gaap:RelatedPartyMember2026-01-012026-09-300001636639fihl:FrameworkAgreementMemberfihl:ThirdPartyManagingGeneralUnderwritersMemberus-gaap:RelatedPartyMember2026-01-012026-09-300001636639fihl:FrameworkAgreementMemberus-gaap:RelatedPartyMember2026-07-012026-09-300001636639fihl:FrameworkAgreementMemberus-gaap:RelatedPartyMember2025-07-012025-09-300001636639fihl:FrameworkAgreementMemberus-gaap:RelatedPartyMember2025-01-012025-09-300001636639fihl:FrameworkAgreementMemberfihl:PolicyAcquisitionExpenseus-gaap:RelatedPartyMember2026-07-012026-09-300001636639fihl:FrameworkAgreementMemberfihl:PolicyAcquisitionExpenseus-gaap:RelatedPartyMember2026-01-012026-09-300001636639fihl:FrameworkAgreementMemberfihl:PolicyAcquisitionExpenseus-gaap:RelatedPartyMember2025-07-012025-09-300001636639fihl:FrameworkAgreementMemberfihl:PolicyAcquisitionExpenseus-gaap:RelatedPartyMember2025-01-012025-09-300001636639fihl:FrameworkAgreementMemberus-gaap:GeneralAndAdministrativeExpenseus-gaap:RelatedPartyMember2026-07-012026-09-300001636639fihl:FrameworkAgreementMemberus-gaap:GeneralAndAdministrativeExpenseus-gaap:RelatedPartyMember2026-01-012026-09-300001636639fihl:FrameworkAgreementMemberus-gaap:GeneralAndAdministrativeExpenseus-gaap:RelatedPartyMember2025-07-012025-09-300001636639fihl:FrameworkAgreementMemberus-gaap:GeneralAndAdministrativeExpenseus-gaap:RelatedPartyMember2025-01-012025-09-300001636639fihl:ProgramMember2026-02-200001636639fihl:PineBrookFealIntermediateL.PMember2026-07-012026-09-300001636639fihl:PineBrookFealIntermediateL.PMember2026-01-012026-09-300001636639fihl:CVCFalconHoldingsLimitedMember2026-01-012026-09-300001636639fihl:FidelisPartnershipMember2026-07-012026-09-300001636639fihl:FidelisPartnershipMember2026-01-012026-09-300001636639fihl:FidelisPartnershipMember2025-07-012025-09-300001636639fihl:FidelisPartnershipMember2025-01-012025-09-3000016366392025-01-012025-12-3100016366392026-01-012026-03-310001636639us-gaap:SubsequentEventMember2026-11-030001636639us-gaap:SubsequentEventMember2026-11-032026-11-03


PELAGOS INSURANCE CAPITAL LIMITED
Unaudited Consolidated Financial Statements
For the Three and Nine Months Ended September 30, 2026 and 2025
1


PELAGOS INSURANCE CAPITAL LIMITED
TABLE OF CONTENTS
Page
Financial Statements
Consolidated Balance Sheets
3
September 30, 2026 (unaudited) and December 31, 2025
Consolidated Statements of Income and Comprehensive Income
4
For the three and nine months ended September 30, 2026 and 2025 (unaudited)
Consolidated Statements of Changes in Shareholders’ Equity
5
For the three and nine months ended September 30, 2026 and 2025 (unaudited)
Consolidated Statements of Cash Flows
6
For the nine months ended September 30, 2026 and 2025 (unaudited)
Notes to the Unaudited Consolidated Financial Statements
Note 1. Nature of Operations
7
Note 2. Significant Accounting Policies
7
Note 3. Segments
8
Note 4. Investments
12
Note 5. Fair Value Measurements
16
Note 6. Total Cash, Cash Equivalents, Restricted Cash and Restricted Investments
20
Note 7. Derivative Financial Instruments
20
Note 8. Reserves for Losses and Loss Adjustment Expenses
21
Note 9. Reinsurance and Retrocessional Reinsurance
22
Note 10. Long Term Debt
22
Note 11. Commitments and Contingencies
23
Note 12. Related Party Transactions
24
Note 13. Earnings Per Share
25
Note 14. Share Capital Authorized and Issued
26
Note 15. Income Taxes
26
Note 16. Subsequent Events
27
Management’s Discussion and Analysis of Financial Condition and Results of Operation
Overview
28
Performance Measures and Non-GAAP Financial Measures
29
Results of Operations
33
Financial Condition, Liquidity and Capital Resources
37
Quantitative and Qualitative Disclosures about Market Risk
39
Cautionary Note Regarding Forward-Looking Statements
39

2


PELAGOS INSURANCE CAPITAL LIMITED
Consolidated Balance Sheets
At September 30, 2026 (Unaudited) and December 31, 2025
(Expressed in millions of U.S. dollars, except for share and per share amounts)
September 30,
2026
December 31, 2025
Assets
Fixed maturity securities, available-for-sale, at fair value
(amortized cost: $2,839.1, 2025: $2,590.6 (net of allowance for credit losses of $19.3, 2025: $0.6))
$2,792.7 $2,640.4 
Short-term investments, available-for-sale, at fair value
(amortized cost: $269.1, 2025: $111.3 (net of allowance for credit losses of $nil, 2025: $nil))
268.7 111.3 
Other investments, at fair value 661.5 485.7 
Total investments3,722.9 3,237.4 
Cash and cash equivalents446.1 873.0 
Restricted cash and cash equivalents80.2 374.6 
Accrued investment income24.9 28.3 
Premiums and other receivables (net of allowance for credit losses of $14.9, 2025: $15.8)
4,038.1 3,322.2 
Amounts due from The Fidelis Partnership (net of allowance for credit losses of $nil, 2025: $nil)
320.4 174.8 
Deferred reinsurance premiums1,604.7 1,441.5 
Reinsurance balances recoverable on paid losses (net of allowance for credit losses of $0.3, 2025: $0.3)
366.0 438.7 
Reinsurance balances recoverable on reserves for losses and loss adjustment expenses
(net of allowance for credit losses of $0.9, 2025: $0.9)
1,312.4 1,195.6 
Deferred policy acquisition costs
(includes The Fidelis Partnership deferred commissions of $279.6, 2025: $243.4)
1,329.5 1,085.0 
Other assets170.2 272.7 
Total assets$13,415.4 $12,443.8 
Liabilities and shareholders' equity
Liabilities
Reserves for losses and loss adjustment expenses$2,930.6 $2,607.1 
Unearned premiums5,153.9 4,384.8 
Reinsurance balances payable1,702.7 1,659.6 
Amounts due to The Fidelis Partnership 641.9 457.7 
Long term debt720.8 843.2 
Other liabilities124.3 91.8 
Total liabilities11,274.2 10,044.2 
Commitments and contingencies
Shareholders' equity
Common shares ($0.01 par, issued and outstanding: 79,345,285, 2025: 96,651,534)
0.8 1.0 
Additional paid-in capital1,330.4 1,685.6 
Accumulated other comprehensive income/(loss)(41.6)37.1 
Retained earnings851.6 675.9 
Total shareholders' equity2,141.2 2,399.6 
Total liabilities and shareholders' equity$13,415.4 $12,443.8 
See accompanying notes to the consolidated financial statements
3


PELAGOS INSURANCE CAPITAL LIMITED
Consolidated Statements of Income and Comprehensive Income (Unaudited)
For the three and nine months ended September 30, 2026 and September 30, 2025
(Expressed in millions of U.S. dollars, except for share and per share amounts)
Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Revenues
Gross premiums written$839.8 $797.5 $3,977.0 $3,739.4 
Reinsurance premiums ceded(247.5)(293.3)(1,435.2)(1,509.9)
Net premiums written592.3 504.2 2,541.8 2,229.5 
Change in net unearned premiums191.4 95.6 (608.5)(488.7)
Net premiums earned783.7 599.8 1,933.3 1,740.8 
Net investment income44.6 45.9 132.3 140.0 
Net realized and unrealized investment gains/(losses)(27.4)6.2 (4.1)18.8 
Total revenues800.9 651.9 2,061.5 1,899.6 
Expenses
Losses and loss adjustment expenses351.9 180.7 868.3 906.6 
Policy acquisition expenses (includes The Fidelis Partnership commissions of $96.8 and $254.1 (2025: $87.1 and $236.1))
335.3 266.4 831.0 752.3 
General and administrative expenses29.5 27.2 88.0 71.5 
Corporate and other expenses0.3 — 3.0 1.2 
Net foreign exchange (gains)/losses(2.0)1.7 2.0 2.2 
Financing costs12.5 15.1 39.8 33.1 
Total expenses727.5 491.1 1,832.1 1,766.9 
Income before income taxes73.4 160.8 229.4 132.7 
Income tax expense(11.7)(30.3)(15.3)(25.0)
Net income$61.7 $130.5 $214.1 $107.7 
Other comprehensive income/(loss)
Unrealized gains/(losses) on available-for-sale investments$(62.6)$10.5 $(100.1)$47.1 
Reclassification of net realized losses/(gains) recognized in net income2.7 (1.3)3.4 (2.9)
Income tax (expense)/benefit, all of which relates to unrealized gains/(losses) on available-for-sale investments11.0 (1.8)18.0 (8.6)
Total other comprehensive income/(loss)(48.9)7.4 (78.7)35.6 
Comprehensive income$12.8 $137.9 $135.4 $143.3 
Per share data
Earnings per common share
Earnings per common share$0.75 $1.25 $2.48 $1.00 
Earnings per diluted common share$0.74 $1.24 $2.46 $0.99 
Weighted average common shares outstanding81,899,656 104,370,380 86,384,660 108,156,265 
Weighted average diluted common shares outstanding83,022,195 105,006,130 87,162,021 108,635,908 
See accompanying notes to the consolidated financial statements
4


PELAGOS INSURANCE CAPITAL LIMITED
Consolidated Statements of Changes in Shareholders’ Equity (Unaudited)
For the three and nine months ended September 30, 2026 and September 30, 2025
(Expressed in millions of U.S. dollars)
Three Months EndedNine Months Ended
September 30,
2026
September 30, 2025September 30,
2026
September 30, 2025
Common shares
Balance - beginning of period$0.8 $1.0 $1.0 $1.2 
Common shares repurchased and retired— — (0.2)(0.2)
Balance - end of period0.8 1.0 0.8 1.0 
Common shares held in treasury, at cost
Balance - beginning of period— — — (105.5)
Retirement of treasury shares— — — 105.5 
Balance - end of period— — — — 
Additional paid-in capital
Balance - beginning of period1,409.9 1,831.2 1,685.6 2,044.6 
Share compensation expense3.6 2.4 8.8 5.3 
Common shares repurchased and retired(83.0)(31.9)(362.3)(248.0)
Shares withheld for employee taxes on restricted share unit vesting(0.1)— (1.7)(0.2)
Balance - end of period1,330.4 1,801.7 1,330.4 1,801.7 
Accumulated other comprehensive income/(loss), net of tax
Unrealized gains/(losses) on available-for-sale securities, net of tax
Balance - beginning of period7.3 32.7 37.1 4.5 
Unrealized gains/(losses) arising during the period, net of reclassification adjustment(48.9)7.4 (78.7)35.6 
Balance – end of period(41.6)40.1 (41.6)40.1 
Retained earnings
Balance – beginning of period802.5 458.5 675.9 503.6 
Net income61.7 130.5 214.1 107.7 
Dividends on common shares(12.6)(15.7)(38.4)(38.0)
Balance - end of period851.6 573.3 851.6 573.3 
Total shareholders' equity attributable to common shareholders$2,141.2 $2,416.1 $2,141.2 $2,416.1 
See accompanying notes to the consolidated financial statements
5


PELAGOS INSURANCE CAPITAL LIMITED
Consolidated Statements of Cash Flows (Unaudited)
For the nine months ended September 30, 2026 and September 30, 2025
(Expressed in millions of U.S. dollars)
September 30,
2026
September 30, 2025
Operating activities
Net income$214.1 $107.7 
Adjustments to reconcile net income after tax to net cash provided by/(used in) operating activities:
Share compensation expense8.8 5.3 
Accretion, amortization and depreciation(10.0)(15.3)
Net realized and unrealized (gain)/loss on investments4.1 (18.8)
Deferred tax expense8.7 0.2 
Net changes in assets and liabilities:
Accrued investment income3.4 11.4 
Premiums and other receivables(744.6)(467.5)
Amounts due from The Fidelis Partnership(145.9)(166.8)
Deferred reinsurance premiums(163.2)(238.5)
Reinsurance balances recoverable on paid losses67.2 (88.4)
Reinsurance balances recoverable on reserves for losses and loss adjustment expenses(125.3)147.8 
Deferred policy acquisition costs(244.5)(186.5)
Other assets93.3 2.5 
Reserves for losses and loss adjustment expenses341.7 (866.0)
Unearned premiums769.1 726.4 
Reinsurance balances payable65.9 245.9 
Amounts due to The Fidelis Partnership188.5 146.1 
Other liabilities50.2 17.4 
Net cash provided by/(used in) operating activities381.5 (637.1)
Investing activities
Purchase of available-for-sale securities(2,458.5)(1,293.8)
Proceeds from maturities of available-for-sale securities555.1 506.7 
Proceeds from sales of available-for-sale securities1,488.9 1,591.8 
Proceeds from sale of other investments5.8 — 
Purchase of other investments(163.5)(185.5)
Purchase of fixed assets(0.9)(1.0)
Net cash provided by/(used in) investing activities(573.1)618.2 
Financing activities
Proceeds from issuance of debt, net of issuance costs— 393.3 
Dividends on common shares(38.0)(37.4)
Repurchase of common shares(362.5)(142.7)
Tax paid on withholding shares(1.7)(0.2)
Redemption of junior notes(125.0)— 
Repurchase of preferred securities— (59.6)
Net cash provided by/(used in) financing activities(527.2)153.4 
Effect of exchange rate changes on foreign currency cash(2.5)7.9 
Net increase/(decrease) in cash, restricted cash, and cash equivalents(721.3)142.4 
Cash, restricted cash, and cash equivalents, beginning of period1,247.6 946.6 
Cash, restricted cash, and cash equivalents, end of period$526.3 $1,089.0 
Cash, restricted cash, and cash equivalents comprise the following:
Cash and cash equivalents$446.1 $892.5 
Restricted cash and cash equivalents80.2 196.5 
Cash, restricted cash, and cash equivalents$526.3 $1,089.0 
See accompanying notes to the consolidated financial statements
6



PELAGOS INSURANCE CAPITAL LIMITED
Notes to Consolidated Financial Statements (Unaudited)
(Expressed in millions of U.S. dollars)
1.          Nature of Operations
Pelagos Insurance Capital Limited, formerly known as Fidelis Insurance Holdings Limited (“Pelagos” or “PLGO,” and together with its subsidiaries, the “Company”) is a holding company which was incorporated under the laws of Bermuda on August 22, 2014. The Company is a global specialty underwriter of insurance and reinsurance. Pelagos’ principal operating subsidiaries are:
•Pelagos Insurance Capital Bermuda Limited (formerly known as Fidelis Insurance Bermuda Limited or “FIBL”) (“PICB”) is a Class 4 Bermuda domiciled company which writes most of the Company’s reinsurance business, as well as writing insurance lines. PICB is regulated by the Bermuda Monetary Authority.
•Pelagos Insurance Capital Underwriting Limited (formerly known as Fidelis Underwriting Limited or “FUL”) (“PICUK”) is a company incorporated in England and Wales which principally writes insurance, as well as reinsurance. PICUK is regulated by the Prudential Regulation Authority (“PRA”) and the Financial Conduct Authority (“FCA”).
•Pelagos Insurance Capital Ireland DAC (formerly known as Fidelis Insurance Ireland DAC or “FIID”) (“PICI”) is a Republic of Ireland domiciled company that writes insurance and reinsurance within the European Economic Area. PICI is regulated by the Central Bank of Ireland (“CBI”).
•Pelagos (UK) Services Limited (formerly known as FIHL (UK) Services Limited or “FSL”) (“PSL”) is a service company incorporated in England and Wales, that also has a branch in Ireland.
•Nameco (No 1404) Limited (the “Pelagos Corporate Member”), a wholly owned subsidiary of PICB, is a Lloyd’s corporate member that facilitates the Company’s participation in underwriting activities for Lloyd’s of London Syndicates. The Company currently participates in the underwriting activity of Syndicate 3123, with a participation rate of 7.4% for the 2026 and 2025 years of account. Effective January 1, 2026, the Company also began participating in the underwriting activity of other Lloyd’s Syndicates.
On January 3, 2023, the Company distributed its investment in Fidelis Marketing Limited (“FML”) and Pine Walk Capital Limited (“Pine Walk”) to shareholders to form a new managing general underwriter business (“The Fidelis Partnership” or “TFP”) and The Fidelis Partnership was acquired by a consortium of investors.
Through various long-term contractual agreements, effective from January 1, 2023 TFP manages origination, underwriting, underwriting administration and claims handling for business sourced through TFP under delegated authority agreements with the Company. Other services provided by TFP to the Company include sourcing and administering outwards reinsurance, support with business planning, capital management, insurance contract accounting and information technology.
On July 3, 2023, the Company completed an initial public offering of common shares on the New York Stock Exchange.
Following shareholder approval at the Annual General Meeting on April 28, 2026, the Company rebranded as Pelagos Insurance Capital, with the legal name change becoming effective May 11, 2026. The Company is now trading on the New York Stock Exchange under ticker symbol “PLGO.”
2.    Significant Accounting Policies
Basis of presentation
The unaudited consolidated financial statements include the results of Pelagos and its subsidiaries and have been prepared in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These unaudited financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2025, in Pelagos’ Form 20-F filed with the Securities and Exchange Commission on March 5, 2026.
All intercompany balances and transactions have been eliminated on consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. In the opinion of management, the accompanying unaudited interim consolidated financial statements reflect all adjustments (consisting of normally recurring accruals) necessary for a fair statement of results on an interim basis. The results of any interim period are not necessarily indicative of the results for a full year or any future periods. The consolidated financial statements have been prepared on a going concern basis.
7


Reporting currency
The financial information is reported in United States dollars (“U.S. dollars” or “$”), expressed in millions, except for share and per share amounts.
Significant Accounting Policies
There were no notable changes to the Company’s significant accounting policies subsequent to December 31, 2025.
3.           Segments
The chief operating decision maker (“CODM”) reviews the Company’s ongoing underwriting operations across two operating segments: Insurance and Reinsurance. In determining how to allocate resources and assess the performance of the Company’s underwriting results, management considers many factors including the nature of the insurance product offered, the risks that are covered and the nature of the client.
•The Insurance segment comprises a specialized portfolio of risks that includes Property, Marine, Asset Backed Finance & Portfolio Credit, Energy, Cyber, Aviation & Aerospace, Political Risk, Violence & Terror, and Other Insurance risks.
•The Reinsurance segment is primarily a property catastrophe book, with a smaller proportion of Retro & Whole Account business.
The Company also has an “Other” category that includes general and administrative expenses and The Fidelis Partnership commissions.
Assets are not allocated to segments, nor are general and administrative expenses allocated between segments as employees, including underwriters, may work across different segments. The Fidelis Partnership commissions (see Note 12, Related Party Transactions) are not allocated to segments as they are not included in the measure of segment profit reviewed by the CODM, nor is a segment analysis of such expenses provided in other information reviewed by the CODM.
8


The following tables summarize the Company’s segment disclosures:
Three Months Ended September 30, 2026
InsuranceReinsuranceOtherTotal
Gross premiums written$686.1 $153.7 $— $839.8 
Net premiums written520.5 71.8 — 592.3 
Net premiums earned634.0 149.7 — 783.7 
Losses and loss adjustment expenses(341.6)(10.3)— (351.9)
Policy acquisition expenses(193.8)(44.7)(96.8)(335.3)
General and administrative expenses— — (29.5)(29.5)
Underwriting income98.6 94.7 67.0 
Net investment income44.6 
Net realized and unrealized investment losses(27.4)
Corporate and other expenses(0.3)
Net foreign exchange gains2.0 
Financing costs(12.5)
Income before income taxes73.4 
Income tax expense(11.7)
Net income$61.7 
Losses and loss adjustment expenses incurred - current year
(325.8)(21.4)$(347.2)
Losses and loss adjustment expenses incurred - prior accident years
(15.8)11.1 (4.7)
Losses and loss adjustment expenses incurred - total
$(341.6)$(10.3)$(351.9)
Underwriting Ratios(1)
Loss ratio - current year51.4%14.3%44.3%
Loss ratio - prior accident years2.5%(7.4%)0.6%
Loss ratio - total53.9%6.9%44.9%
Policy acquisition expense ratio30.6%29.9%30.4%
Underwriting ratio84.5%36.8%75.3%
The Fidelis Partnership commissions ratio12.4%
General and administrative expense ratio3.8%
Combined ratio91.5%
_________________
(1)Underwriting ratios are calculated by dividing the related expense by net premiums earned.
9


Three Months Ended September 30, 2025
InsuranceReinsuranceOtherTotal
Gross premiums written$605.8 $191.7 $— $797.5 
Net premiums written388.5 115.7 — 504.2 
Net premiums earned456.5 143.3 — 599.8 
Losses and loss adjustment expenses(177.0)(3.7)— (180.7)
Policy acquisition expenses(137.2)(42.1)(87.1)(266.4)
General and administrative expenses— — (27.2)(27.2)
Underwriting income142.3 97.5 125.5 
Net investment income45.9 
Net realized and unrealized investment gains6.2 
Net foreign exchange losses(1.7)
Financing costs(15.1)
Income before income taxes160.8 
Income tax expense(30.3)
Net income$130.5 
Losses and loss adjustment expenses incurred - current year
(179.7)(17.0)$(196.7)
Losses and loss adjustment expenses incurred - prior accident years
2.7 13.3 16.0 
Losses and loss adjustment expenses incurred - total
$(177.0)$(3.7)$(180.7)
Underwriting Ratios(1)
Loss ratio - current year39.4%11.9%32.8%
Loss ratio - prior accident years(0.6%)(9.3%)(2.7%)
Loss ratio - total38.8%2.6%30.1%
Policy acquisition expense ratio30.1%29.4%29.9%
Underwriting ratio68.9%32.0%60.0%
The Fidelis Partnership commissions ratio14.5%
General and administrative expense ratio4.5%
Combined ratio79.0%
__________________
(1)Underwriting ratios are calculated by dividing the related expense by net premiums earned.
10


Nine Months Ended September 30, 2026
InsuranceReinsuranceOtherTotal
Gross premiums written$3,035.7 $941.3 $— $3,977.0 
Net premiums written2,068.0 473.8 — 2,541.8 
Net premiums earned1,663.6 269.7 — 1,933.3 
Losses and loss adjustment expenses(870.6)2.3 — (868.3)
Policy acquisition expenses(496.9)(80.0)(254.1)(831.0)
General and administrative expenses— — (88.0)(88.0)
Underwriting income296.1 192.0 146.0 
Net investment income132.3 
Net realized and unrealized investment losses(4.1)
Corporate and other expenses(3.0)
Net foreign exchange losses(2.0)
Financing costs(39.8)
Income before income taxes229.4 
Income tax expense(15.3)
Net income$214.1 
Losses and loss adjustment expenses incurred - current year
(860.3)(39.1)$(899.4)
Losses and loss adjustment expenses incurred - prior accident years
(10.3)41.4 31.1 
Losses and loss adjustment expenses incurred - total
$(870.6)$2.3 $(868.3)
Underwriting Ratios(1)
Loss ratio - current year51.7%14.5%46.5%
Loss ratio - prior accident years0.6%(15.4%)(1.6%)
Loss ratio - total52.3%(0.9%)44.9%
Policy acquisition expense ratio29.9%29.7%29.8%
Underwriting ratio82.2%28.8%74.7%
The Fidelis Partnership commissions ratio13.1%
General and administrative expense ratio4.6%
Combined ratio92.4%
_________________
(1)Underwriting ratios are calculated by dividing the related expense by net premiums earned.


11


Nine Months Ended September 30, 2025
InsuranceReinsuranceOtherTotal
Gross premiums written$2,775.1 $964.3 $— $3,739.4 
Net premiums written1,743.6 485.9 — 2,229.5 
Net premiums earned1,427.3 313.5 — 1,740.8 
Losses and loss adjustment expenses(750.2)(156.4)— (906.6)
Policy acquisition expenses(434.3)(81.9)(236.1)(752.3)
General and administrative expenses— — (71.5)(71.5)
Underwriting income242.8 75.2 10.4 
Net investment income140.0 
Net realized and unrealized investment gains18.8 
Corporate and other expenses(1.2)
Net foreign exchange losses(2.2)
Financing costs(33.1)
Income before income taxes132.7 
Income tax expense(25.0)
Net income$107.7 
Losses and loss adjustment expenses incurred - current year
(647.0)(227.2)$(874.2)
Losses and loss adjustment expenses incurred - prior accident years
(103.2)70.8 (32.4)
Losses and loss adjustment expenses incurred - total
$(750.2)$(156.4)$(906.6)
Underwriting Ratios(1)
Loss ratio - current year45.4%72.5%50.2%
Loss ratio - prior accident years7.2%(22.6%)1.9%
Loss ratio - total52.6%49.9%52.1%
Policy acquisition expense ratio30.4%26.1%29.7%
Underwriting ratio83.0%76.0%81.8%
The Fidelis Partnership commissions ratio13.6%
General and administrative expense ratio4.1%
Combined ratio99.5%
__________________
(1)Underwriting ratios are calculated by dividing the related expense by net premiums earned.
4.           Investments
At September 30, 2026, the Company’s investments are substantially all managed by external investment managers through individual investment management agreements. The Company monitors activity and performance of the external managers on an ongoing basis.
a.Fixed maturity securities
The following table summarizes the fair value of fixed maturity investments:
September 30, 2026
Amortized CostUnrealized
gains
Unrealized
losses
Fair
value
U.S. Treasuries$343.0 $— $(6.7)$336.3 
Non-U.S. government39.1 — (0.5)38.6 
Corporate bonds1,730.7 1.5 (34.3)1,697.9 
Residential mortgage-backed428.8 0.1 (4.5)424.4 
Commercial mortgage-backed10.3 — (0.2)10.1 
Other asset-backed securities287.2 0.3 (2.1)285.4 
Total fixed maturity securities$2,839.1 $1.9 $(48.3)$2,792.7 
12


December 31, 2025
Amortized CostUnrealized
gains
Unrealized
losses
Fair
value
U.S. Treasuries$477.8 $6.6 $(0.2)$484.2 
Agencies6.9 — — 6.9 
Non-U.S. government46.6 0.6 — 47.2 
Corporate bonds1,616.8 35.7 (0.3)1,652.2 
Residential mortgage-backed244.3 5.6 — 249.9 
Commercial mortgage-backed1.0 — — 1.0 
Other asset-backed securities197.2 1.9 (0.1)199.0 
Total fixed maturity securities$2,590.6 $50.4 $(0.6)$2,640.4 
Review of the fixed maturity securities is performed on a regular basis to consider concentration, credit quality and compliance with established guidelines. For individual fixed maturity securities, nationally recognized statistical rating organizations are used and the middle of three ratings or the lower of two is taken. The composition of the fair values of fixed maturity securities by credit rating is as follows:
September 30, 2026December 31, 2025
Fair Value%Fair Value%
AAA$286.1 10%$216.1 9%
AA886.1 32%891.2 34%
A1,182.2 42%1,118.8 42%
BBB413.7 15%382.8 14%
Below BBB24.6 1%31.5 1%
Total fixed maturity securities$2,792.7 100%$2,640.4 100%
The contractual maturities for fixed maturity securities are listed in the following table:
September 30, 2026December 31, 2025
Amortized CostFair ValueAmortized CostFair Value
Due in one year or less$145.6 $145.8 $233.0 $234.2 
Due after one year through five years1,513.7 1,496.8 1,503.5 1,532.4 
Due after five years through ten years623.5 602.4 520.3 534.3 
Due after ten years556.3 547.7 333.8 339.5 
Total fixed maturity securities$2,839.1 $2,792.7 $2,590.6 $2,640.4 
Expected maturities may differ from contractual maturities as borrowers may have the right to call or repay obligations with or without call or prepayment penalties. Additionally, lenders may have the right to put the securities back to the borrower.
b.Short-term investments
The Company’s short-term investments consist of U.S. Treasuries, corporate bonds and other asset-backed securities with maturities of 90 days or greater but less than one year at the time of purchase:
September 30, 2026
Amortized CostUnrealized
gains
Unrealized
losses
Fair
value
U.S. Treasuries$267.3 $— $(0.4)$266.9 
Corporate bonds1.4 — — 1.4 
Other asset-backed securities0.4 — — 0.4 
Total short-term investments
$269.1 $— $(0.4)$268.7 
December 31, 2025
Amortized CostUnrealized
gains
Unrealized
losses
Fair
value
U.S. Treasuries$109.9 $— $— $109.9 
Corporate bonds1.0 — — 1.0 
Other asset-backed securities0.4 — — 0.4 
Total short-term investments
$111.3 $— $— $111.3 
13


The composition of the fair values of short-term investments by credit rating is as follows:
September 30, 2026December 31, 2025
Fair Value%Fair Value%
AAA$0.4 —%$0.4 —%
AA266.9 100%109.9 99%
A0.8 —%0.7 1%
BBB0.6 —%0.3 —%
Total short-term investments$268.7 100%$111.3 100%
c.Available-for-sale - net loss position
The following table summarizes, by type of security, the aggregate fair value and gross unrealized loss by length of time the security has been in an unrealized loss position for the Company’s available-for-sale portfolio:
September 30, 2026
0 - 12 months> 12 months
Fair
value
Gross unrealized lossesGross unrealized lossesNumber of securities
U.S. Treasuries$552.4 $(7.1)$— 169 
Non-U.S. government35.5 (0.5)— 26 
Corporate bonds1,290.7 (34.2)(0.1)957 
Residential mortgage-backed262.7 (4.5)— 113 
Commercial mortgage-backed8.3 (0.2)— 14 
Other asset-backed securities181.5 (2.1)— 110 
Total$2,331.1 $(48.6)$(0.1)1,389 
December 31, 2025
0 - 12 months> 12 months
Fair
value
Gross unrealized lossesGross unrealized lossesNumber of securities
U.S. Treasuries$50.1 $(0.1)$(0.1)49 
Non-U.S. government5.3 — — 3 
Corporate bonds53.3 (0.3)— 132 
Residential mortgage-backed2.2 — — 1 
Other asset-backed securities25.3 (0.1)— 30 
Total$136.2 $(0.5)$(0.1)215 
At September 30, 2026 on a security level basis, 1,389 securities out of a total of approximately 2,031 securities were in an unrealized loss position and the largest unrealized loss from a single security in the Company’s fixed maturity portfolio was $(1.2) million. At December 31, 2025, on a security level basis, 215 securities out of a total of approximately 1,624 securities were in an unrealized loss position and the largest unrealized loss from a single security in the Company’s fixed maturity portfolio was $0.1 million.
d.Allowance for expected credit losses - available-for-sale
The following table provides a roll forward of the allowance for expected credit losses of the Company’s securities classified as available-for-sale:
Three months endedNine months ended
September 30,
2026
September 30, 2025September 30,
2026
September 30, 2025
Balance at beginning of period$3.6 $0.6 $0.6 $5.9 
Expected credit losses on securities where credit losses were not previously recognized10.6 0.4 14.5 1.1 
Additions/(reductions) for expected credit losses on securities where credit losses were previously recognized5.4 (0.6)5.2 (5.8)
Securities sold/redeemed/matured(0.3)(0.1)(1.0)(0.9)
Balance at end of period$19.3 $0.3 $19.3 $0.3 
14


The Company assesses each quarter whether the decline in fair value of an available-for-sale security below its amortized cost is the result of a credit loss. All available-for-sale securities with unrealized losses are reviewed. The Company considers many factors to determine whether a credit loss exists, including the extent to which fair value is below cost, the implied yield to maturity, rating downgrades of the security and whether or not the issuer has failed to make scheduled principal or interest payments. The Company also takes into consideration information about the financial condition of the issuer and industry factors that could negatively impact the capital markets.
If the decline in fair value of an available-for-sale security below its amortized cost is considered to be the result of a credit loss, the Company compares the estimated present value of the cash flows expected to be collected to the amortized cost of the security. The extent to which the estimated present value of the cash flows expected to be collected is less than the amortized cost of the security represents the expected credit loss, which is recorded as an allowance and recognized in net income.
e.Other investments, at fair value
The following table provides a summary of the Company’s other investments by investment strategy:
September 30, 2026December 31, 2025
Fair Value%Fair Value%
Fixed income funds$272.8 41%$243.0 50%
Hedge funds
Credit25.7 3%25.0 5%
Global macro49.7 8%41.6 9%
Long/short189.5 29%67.4 14%
Multi-strategy and event-driven99.3 15%96.8 20%
Total hedge funds364.2 55%230.8 48%
Private credit funds24.54%11.92%
Total other investments$661.5 100%$485.7 100%
The fixed income fund investments are structured as commingled investment funds managed by third-party managers. In 2025 the Company invested in:
•A UCITS (Undertakings for Collective Investment in Transferable Securities) fund that is actively investing in primarily global investment-grade credit securities. The fund has an average credit rating of A.
•An ICAV (Irish collective asset-management vehicle) fund that is structured as a limited partnership. The fund invests in a diverse portfolio of primarily high yield corporate debt securities and bank loans. The fund has an average credit rating of BB-.
•An open-ended Luxembourg based fund that is investing in investment-grade and short-dated subscription line financing for private funds. The fund has an average credit rating of AA.
At September 30, 2026, approximately $nil (December 31, 2025: $63.4 million) of the fixed income funds were subject to lock-ups or hold-backs and are not redeemable within twelve months. The remaining funds can be redeemed within 30 days’ notice.
At September 30, 2026, the Company had $nil (December 31, 2025: $12.2 million) of unfunded investment commitments to fixed income funds, which are callable by the relevant investment managers.
Commencing 2024, the Company invested in a number of hedge funds managed by third-party managers across a range of strategies including credit, global macro, long/short, multi strategy and event-driven.
Other investments in hedge funds are redeemable over periods ranging from one month to greater than twelve months. The common redemption restrictions which may impact the Company's ability to redeem hedge funds are lock-up periods, hold-backs and gates. A lock-up period is the initial amount of time an investor is contractually required to remain invested in the fund before having the ability to redeem in whole or in part. A hold-back entitles the fund to retain up to 10% of a total redemption request, pending completion of the external audit for the financial year in which the redemption occurs. A gate is a suspension of redemptions which may be implemented by the investment manager of the fund to defer, in whole or in part, the redemption request in the event the aggregate amount of redemption requests exceeds a specified percentage of the fund’s net assets. At September 30, 2026, approximately 86% (December 31, 2025: 94%) of the total hedge fund investment can be redeemed within the next twelve months, while approximately 14% (December 31, 2025: 6%) of the total hedge fund investment could be subject to lock-ups or hold-backs and are not redeemable within twelve months. At September 30, 2026, approximately 4% (December 31, 2025: 1%) of the hedge funds were subject to a gate.
15


Commencing 2025, the Company invested in private credit funds managed by third-party managers. The private credit fund strategy includes investing in portfolio debt securities related to certain private credit asset classes, including direct lending, specialty finance and credit opportunities.
At September 30, 2026 the Company had $96.3 million (December 31, 2025: $108.1 million) of unfunded commitments as a limited partner in private credit funds. The Company generally has no right to redeem its interest in any of these private credit funds in advance of dissolution of the applicable limited partnerships. Instead, distributions are received by the Company in connection with the liquidation or maturity of the underlying private credit assets of the fund. It is estimated that the majority of the underlying assets of the limited partnerships will liquidate over 5 to 10 years from inception of the limited partnership.
f.Net investment income and net realized and unrealized investment gains
The components of net investment return are as follows:
Three Months EndedNine Months Ended
September 30,
2026
September 30, 2025September 30,
2026
September 30, 2025
Net interest and dividend income$45.8 $47.9 $137.4 $146.2 
Investment expenses(1.2)(2.0)(5.1)(6.2)
Net investment income44.6 45.9 132.3 140.0 
Net realized gains/(losses) on fixed maturity securities, available-for-sale(2.7)1.3 (3.4)2.9 
Net realized gain on derivatives— — 0.1 — 
Net realized and unrealized gains/(losses) on other investments(9.0)4.7 17.9 10.4 
Change in net unrealized losses on derivatives— (0.1)— (0.1)
Change in provision for expected credit losses (15.7)0.3 (18.7)5.6 
Net realized and unrealized investment gains/(losses)(27.4)6.2 (4.1)18.8 
Total realized and unrealized investment gains/(losses) and net investment income$17.2 $52.1 $128.2 $158.8 
5.           Fair Value Measurements
FASB ASC 820-10, Fair Value Measurements and Disclosures, defines fair value, establishes a consistent framework for measuring fair value and requires disclosures about fair value measurements. The standard requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
Fair value hierarchy
FASB ASC 820-10 specifies a hierarchy of inputs based on whether the inputs are observable or unobservable. Observable inputs are developed using market data and reflect market participant assumptions, while unobservable inputs reflect the Company’s market assumptions. The fair value hierarchy is as follows:
•Level 1: Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities traded in active markets. The fair value is determined by multiplying the quoted price by the quantity held by the Company.
•Level 2: Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices (e.g. interest rates, yield curves, prepayment spreads, default rate, etc.) for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability or can be corroborated by observable market data.
•Level 3: Inputs to the valuation methodology are unobservable for the asset or liability and are significant to the fair value measurement. Significant management assumptions can be used to establish management’s best estimate of the assumptions used by other market participants in determining the fair value of the asset or liability.
As required under the fair value hierarchy, the Company considers relevant and observable market inputs in its valuations where possible. The frequency of transactions, the size of the bid-ask spread and the amount of adjustment necessary when comparing similar transactions are all factors in determining the liquidity of markets and the relevance of observable prices in those markets.
The Company’s policy with respect to transfer between levels of the fair value hierarchy is to recognize transfers into and out of each level as of the end of the reporting period.
Determination of fair value
The following section describes the valuation methodologies used by the Company to measure assets and liabilities at fair value, including an indication of the level within the fair value hierarchy in which each asset or liability is generally classified.
16


Fixed maturity securities, available-for-sale
Fair values for all fixed maturity securities, available-for-sale, are independently provided by the investment administrator, investment custodians, and investment managers, each of which utilize internationally recognized independent pricing services.
For determining the fair value of securities that are not actively traded, in general, pricing services use “matrix pricing” in which the independent pricing service uses observable market inputs including, but not limited to, reported trades, benchmark yields, broker-dealer quotes, interest rates, prepayment spreads, default rates and such other inputs as are available from market sources to determine a reasonable fair value.
The following describes the techniques generally used to determine the fair value of the Company’s fixed maturity securities by asset class.
•U.S. Treasuries are bonds issued by the U.S. government. The significant inputs used to determine the fair value of these securities are based on quoted prices in active markets for identical assets and are therefore classified within Level 1.
•Agency securities consist of securities issued by U.S. and non-U.S. government sponsored agencies such as the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, government development banks and other agencies which are not mortgage pass-through. The fair values of these securities are determined using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads are observable market inputs, the fair values of these securities are classified as Level 2.
•Non-U.S. government securities consist of bonds issued by non-U.S. governments and supranationals. The significant inputs used to determine the fair value of these securities include the spread above the risk-free yield curve, reported trades and broker-dealer quotes. These are considered to be observable market inputs and, therefore, the fair values of these securities are classified within Level 2.
•Corporate bonds consist primarily of investment-grade debt of a wide variety of corporate issuers and industries. When available, significant inputs are used to determine the fair value of these securities and are based on quoted prices in active markets for similar assets. When not available, the fair values of these securities are determined using the spread above the risk-free yield curve, reported trades, broker-dealer quotes, benchmark yields, and industry and market indicators. The fair values of these securities are classified as Level 2.
•Residential mortgage-backed securities include agency mortgage-backed securities and agency collateralized mortgage obligations. These are individually evaluated using option adjusted spreads (“OAS”) and nominal spreads. The OAS valuations use a third-party prepayment model and OAS. Spreads are based upon tranche type and average life volatility. These spreads are gathered from dealer quotes, trade prices, and the new issue market. The fair values of these securities are classified as Level 2.
•Commercial mortgage-backed securities consist of investment grade bonds backed by pools of loans with underlying collateral. Securities held in this sector are primarily priced by pricing services. Inputs to the valuation process include broker-dealer quotes and other available trade information, prepayment speeds, current price data, the swap curve as well as cash settlement. The fair values of these securities are classified as Level 2.
•Other asset-backed securities consist of investment grade bonds backed by pools of loans with underlying collateral. The underlying collateral for asset-backed securities consists mainly of student loans, automobile loans and credit card receivables. These securities are primarily priced by index providers and pricing vendors. Inputs to the valuation process include broker-dealer quotes and other available trade information, prepayment speeds, tranche type, interest rate data and credit spreads. The Company classifies these securities within Level 2.
Short-term investments
The Company’s short-term investments are classified within the fair value hierarchy using the methodologies specified for our fixed maturity securities above.
Other investments
Fair values for the Company’s investments in fixed income funds, hedge funds and private credit funds are based on their respective net asset values and are excluded from the fair value hierarchy table below.
Derivative assets and liabilities
Exchange-traded derivatives, measured at fair value using quoted prices in active markets, where available, are classified as Level 1 of the fair value hierarchy.
Derivatives without quoted prices in an active market and derivatives executed over the counter are valued using internal valuation techniques that consider the time value of money, volatility, the current market and contractual prices of underlying financial instruments. These derivative instruments are classified as either Level 2 or Level 3 depending upon the observability of the
17


significant inputs to the model. The valuation techniques and key inputs depend on the type of derivative and the nature of the underlying instrument.
The following tables present the financial instruments measured at fair value on a recurring basis at September 30, 2026 and December 31, 2025:
September 30, 2026
AssetsLevel 1Level 2Level 3Total
Fixed maturity securities
U.S. Treasuries$336.3 $— $— $336.3 
Non-U.S. government— 38.6 — 38.6 
Corporate bonds— 1,697.9 — 1,697.9 
Residential mortgage-backed— 424.4 — 424.4 
Commercial mortgage-backed— 10.1 — 10.1 
Other asset-backed securities— 285.4 — 285.4 
Total fixed maturity securities336.3 2,456.4 — 2,792.7 
Short-term investments
U.S. Treasuries266.9 — — 266.9 
Corporate bonds— 1.4 — 1.4 
Other asset-backed securities— 0.4 — 0.4 
Total short-term investments266.9 1.8 — 268.7 
Other assets
Investments pending settlement19.5 — — 19.5 
Derivative assets— 0.3 — 0.3 
Total other assets19.5 0.3 — 19.8 
Total assets measured at fair value$622.7 $2,458.5 $— $3,081.2 
Liabilities
Investments pending settlement$(21.3)$— $— $(21.3)
Total other liabilities(21.3)— — (21.3)
Total liabilities measured at fair value$(21.3)$— $— $(21.3)
18


December 31, 2025
AssetsLevel 1Level 2Level 3Total
Fixed maturity securities
U.S. Treasuries$484.2 $— $— $484.2 
Agencies— 6.9 — 6.9 
Non-U.S. government— 47.2 — 47.2 
Corporate bonds— 1,652.2 — 1,652.2 
Residential mortgage-backed— 249.9 — 249.9 
Commercial mortgage-backed— 1.0 — 1.0 
Other asset-backed securities— 199.0 — 199.0 
Total fixed maturity securities484.2 2,156.2 — 2,640.4 
Short-term investments
U.S. Treasuries109.9 — — 109.9 
Corporate bonds— 1.0 — 1.0 
Other asset-backed securities— 0.4 — 0.4 
Total short-term investments109.9 1.4 — 111.3 
Other assets
Investments pending settlement4.8 — — 4.8 
Derivative assets— 2.4 — 2.4 
Total other assets4.8 2.4 — 7.2 
Total assets measured at fair value$598.9 $2,160.0 $— $2,758.9 
Liabilities
Other liabilities
Investments pending settlement$(6.6)$— $— $(6.6)
Derivative liabilities— (1.7)— (1.7)
Total other liabilities(6.6)(1.7)— (8.3)
Total liabilities measured at fair value$(6.6)$(1.7)$— $(8.3)
There were no transfers into or out of Level 1 and Level 2 during the nine months ended September 30, 2026 and the year ended December 31, 2025.

Fair value of financial instrument liabilities
The following table presents financial instruments for which the carrying value differs from the estimated fair values at September 30, 2026 and December 31, 2025. The fair values of the below financial instruments are based on observable inputs and are considered Level 2 measurements.
September 30, 2026December 31, 2025
Fair ValueCarrying ValueFair ValueCarrying Value
7.750% Subordinated notes due 2055
$414.5 $393.8 $431.0 $393.5 
4.875% Senior notes due 2030
314.6 327.0 327.7 326.4 
6.625% Fixed Rate Reset Junior Subordinated notes due 2041
— — 124.4 123.3 

19


6.           Total Cash, Cash Equivalents, Restricted Cash and Restricted Investments
The Company has cash and investments in trust funds that support the insurance contracts written on certain lines of business and in segregated portfolios primarily to provide collateral for letters of credit.
The following table provides a summary of cash and cash equivalents, restricted cash and restricted investments at September 30, 2026 and December 31, 2025:
September 30,
2026
December 31, 2025
Cash and cash equivalents$446.1 $873.0 
Restricted cash securing letter of credit facilities7.4 21.5 
Restricted cash securing insurance and reinsurance contracts72.8 353.1 
Total cash, cash equivalents and restricted cash526.3 1,247.6 
Restricted investments securing reinsurance contracts and letter of credit facilities1,337.2 850.7 
Total cash, cash equivalents, restricted cash and restricted investments$1,863.5 $2,098.3 
7.           Derivative Financial Instruments
The Company enters into derivative instruments such as futures and swaps primarily for fixed income portfolio interest rate and credit exposure management, and forward contracts for foreign currency exposure management. The Company’s derivative instruments are generally traded under International Swaps and Derivatives Association master agreements, which establish the terms of the transactions entered into with the Company’s derivative counterparties. In the event one party becomes insolvent or otherwise defaults on its obligations, a master agreement generally permits the non-defaulting party to accelerate and terminate all outstanding transactions and net the transactions’ marked-to-market values so that a single sum in a single currency will be owed by, or owed to, the non-defaulting party. Effectively, this contractual close-out netting reduces credit exposure from gross to net exposure.
The following table identifies the fair value and notional amounts of derivative instruments included in the Consolidated Balance Sheets, categorized by primary underlying risk:

September 30, 2026December 31, 2025
Derivative assets at fair valueDerivative liabilities at fair value
Notional amounts(1)
Derivative assets at fair valueDerivative liabilities at fair value
Notional amounts(1)
Credit default swaps$— $— $— $2.4 $— $2.2 
Forwards(2)
0.3 — 79.7 — (1.7)133.3 
Total $0.3 $— $2.4 $(1.7)
__________________
(1)The absolute notional exposure represents the Company’s derivative activity, which is representative of the volume of derivatives held during the year.
(2)Contracts used to primarily manage foreign currency risks in underwriting.
The following table presents the Company’s net realized gains/(losses) and change in net unrealized gains/(losses) relating to derivative trading activities for the three and nine months ended September 30, 2026 and 2025. Net realized gains/(losses) and net unrealized gains/(losses) related to derivatives are included in net realized and unrealized investment gains/(losses) and net foreign exchange (gains)/losses in the Consolidated Statements of Income.
Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Net realized gains/(losses)Change in net unrealized
gains/(losses)
Net realized gains/(losses)Change in net unrealized gains/(losses)Net realized gains/(losses)Change in net unrealized
gains/(losses)
Net realized gains/(losses)Change in net unrealized gains/(losses)
Fixed income portfolio management
Credit default swaps$— $— $— $(0.1)$0.1 $— $— $(0.1)
Foreign exchange contracts
Forwards (1)
(0.7)1.9 (4.7)4.5 (0.1)2.0 (16.7)0.6 
Total
$(0.7)$1.9 $(4.7)$4.4 $— $2.0 $(16.7)$0.5 
__________________
(1)Contracts used to primarily manage foreign currency risks in underwriting.
20


The Company obtains and provides collateral from and to counterparties for over-the-counter derivative financial instruments in accordance with bilateral credit facilities.
The Company does not offset its derivative instruments and presents all amounts in the Consolidated Balance Sheets on a gross basis. Unrealized gains are included within other assets and unrealized losses are included within other liabilities. The Company has pledged cash collateral to counterparties to support the current value of amounts due to the counterparties based on the value of the underlying security.
8.           Reserves for Losses and Loss Adjustment Expenses
The reserves for losses and loss adjustment expenses include an amount determined from reported claims, and estimates based on historical loss experience and industry statistics for losses incurred but not reported using a variety of actuarial methods.
The reserve estimates contain an inherent level of uncertainty and actual results may vary, potentially significantly, from the estimates the Company has made. Reserves are reviewed on a quarterly basis and estimates are adjusted to reflect emerging claims experience.
The unpaid reported reserves for losses and loss adjustment expenses are established by management based on reports from brokers, ceding companies and insureds and represent the estimated ultimate cost of events or conditions that have been reported to, or specifically identified by the Company.
Losses and loss adjustment expenses incurred but not reported (“IBNR”) reserves are established by management based on actuarial estimates of ultimate losses and loss adjustment expenses. Inherent in the estimate of ultimate losses and loss adjustment expenses are expected trends in claim severity, frequency of large losses and catastrophes, and other factors which may vary significantly as claims are settled.
Actuarial inputs include the Company’s own loss experience, historical insurance industry loss experience, estimates of pricing adequacy trends and management’s professional judgement. Due to the limited historical data available, reliance is placed upon industry data and a review of individual policies. Estimates are calculated at the lowest level line of business, separately for gross and ceded, and for attritional, large and catastrophic claims.
The Company estimates reserves for unallocated claims adjustment expenses (“ULAE”) based on a percentage of loss reserves as determined by management. However, this may be overridden in exceptional circumstances where this approach is not deemed appropriate. There were no material changes made to the Company’s methodology for calculating reserves for unallocated claims adjustment expenses for the nine months ended September 30, 2026.
Salvage is recorded based on estimated realizable value and is deducted from the reserve for losses and loss adjustment expenses.
The following table presents a reconciliation for the period of reserves for losses and loss adjustment expenses for the nine months ended September 30, 2026 and September 30, 2025:
September 30,
2026
September 30, 2025
Reserves for losses and loss adjustment expenses, beginning of period$2,607.1 $3,134.3 
Reinsurance recoverable on reserves for losses and loss adjustment expenses(1,195.6)(1,255.6)
Net reserves for losses and loss adjustment expenses, beginning of period1,411.5 1,878.7 
Net losses and loss adjustment expenses incurred in respect of losses occurring in:
Current year899.4 874.2 
Prior years(31.1)32.4 
Total incurred
868.3 906.6 
Net losses and loss adjustment expenses paid in respect of losses occurring in:
Current year(65.5)(265.7)
Prior years(587.6)(1,355.3)
Total paid
(653.1)(1,621.0)
Foreign exchange(8.5)25.3 
Net reserves for losses and loss adjustment expenses, end of period1,618.2 1,189.6 
Reinsurance recoverable on reserves for losses and loss adjustment expenses1,312.4 1,131.8 
Reserves for losses and loss adjustment expenses, end of period$2,930.6 $2,321.4 
As a result of the changes in estimates of insured events in prior years, the reserves for losses and loss adjustment expenses net of reinsurance recoveries decreased by $31.1 million for the nine months ended September 30, 2026 (2025: increased by $32.4 million).
21


Net favorable development for the nine months ended September 30, 2026 resulted from better than expected loss development in the Reinsurance segment, partially offset by net adverse development in the Insurance segment.
In the Insurance segment, for the nine months ended September 30, 2026 the net adverse development of $10.3 million was primarily driven by increased loss estimates related to the Baltimore Bridge collapse within our Marine line of business, as well as increased loss estimates in our Political Risk, Violence and Terror line of business and increases in prior year property D&F losses. These increases were partially offset by better than expected loss emergence in multiple lines of business. In the Reinsurance segment, for the nine months ended September 30, 2026 the net favorable development of $41.4 million was driven by positive development on catastrophe losses and benign prior year attritional experience.
Net adverse development for the nine months ended September 30, 2025 resulted from an increase in our Aviation & Aerospace line of business in the Insurance segment related to the Ukraine Conflict, partially offset by better than expected loss development in both operating segments. The favorable development in the Reinsurance segment of $70.8 million was driven by positive development on catastrophe losses and benign prior year attritional experience. The adverse development in the Insurance segment of $103.2 million was driven primarily by an increase in our Aviation & Aerospace line of business related to the Ukraine Conflict. This increase includes the impact of the settlement of certain aviation litigation related claims during the year, as well as the judgment handed down by the English High Court in June 2025. The increase was partially offset by better than expected loss emergence in our Property and Other Insurance lines of business.
9.          Reinsurance and Retrocessional Reinsurance
In the normal course of business, the Company purchases reinsurance and retrocessional protection to mitigate its loss exposure. The Company is exposed to the credit risk of the reinsurers, including the risk that one of its reinsurers becomes insolvent or otherwise unable or unwilling to pay policyholder claims. This credit risk is generally mitigated by either selecting well capitalized, highly rated authorized capacity providers or requiring that the capacity provider post collateral to secure the reinsured risks, which, in some instances, exceeds the related reinsurance recoverable. Allowances are established for amounts deemed uncollectible.
The Company evaluates the financial condition of its reinsurers on a regular basis and monitors concentrations of credit risk with reinsurers. At September 30, 2026, the reinsurance balance recoverable on reserves for losses and loss adjustment expenses was $1,312.4 million (December 31, 2025: $1,195.6 million) and the reinsurance balance recoverable on paid losses was $366.0 million (December 31, 2025: $438.7 million). In evaluating the allowance for expected credit losses, the Company assesses the probability of default and loss given default for each reinsurer. This uses counterparty ratings from a major rating agency and an assessment of the current market conditions for the likelihood of default. An inability of its reinsurers or retrocessionaires to meet their obligations to the Company over the relevant exposure periods for any reason could have a material adverse effect on its financial condition and results of operations.
The allowance for expected credit losses of the Company's reinsurance recoverables on paid losses and on reserves for losses and loss adjustment expenses at September 30, 2026 was $0.3 million and $0.9 million, respectively (December 31, 2025: $0.3 million and $0.9 million, respectively).
10.          Long Term Debt
Long-term debt
On June 13, 2025, the Company issued $400.0 million of its 7.750% Fixed-Rate Reset Subordinated Notes due June 15, 2055 (collectively, the “Subordinated Notes”), with interest payable on June 15 and December 15 of each year, which commenced on December 15, 2025. From the issue date to, but excluding, June 15, 2035, the Subordinated Notes will bear interest at a fixed rate of 7.750% per annum. From and including June 15, 2035, and every five years on June 15 thereafter, the interest rate will reset to the then-current five-year U.S. Treasury rate plus 4.280%, as determined on the applicable reset date. The Subordinated Notes are redeemable at the applicable redemption price, subject to the terms described in the indenture for the Subordinated Notes. However, the Subordinated Notes may not be redeemed if enhanced capital requirements, as established by the Bermuda Monetary Authority (“BMA”), would be breached immediately before or after giving effect to the redemption of such notes, unless the Company replaces the capital represented by the Subordinated Notes to be redeemed or repaid with capital having equal or better capital treatment as the notes under applicable BMA rules. Notwithstanding the foregoing, the Subordinated Notes may not be redeemed prior to June 15, 2030 unless the BMA does not object to such redemption, having been provided notice of the redemption, and the conditions in the foregoing sentence are satisfied. The Subordinated Notes contain covenants, including limitations on liens on the stock of certain designated subsidiaries, limitations on consolidations, mergers, amalgamations and sales of substantially all assets and certain reporting obligations.
On October 16, 2020, the Company issued $105.0 million, and on October 20, 2020, the Company issued a further $20.0 million of its 6.625% Fixed-Rate Reset Junior Subordinated Notes due April 1, 2041 (collectively, the “Junior Notes”) with interest payable on April 1 and October 1 of each year, commencing on April 1, 2021. In April 2026, the Company redeemed its Junior Notes for their
22


principal amount of $125.0 million, plus accrued and unpaid interest up to the redemption date. The Company recorded a corporate expense of $1.7 million in the three months ending June 30, 2026 for the unamortized discount and debt issuance costs.
On June 18, 2020, the Company issued $300.0 million and on July 2, 2020 the Company issued a further $30.0 million of its 4.875% Senior Notes due June 30, 2030 (collectively, the “Senior Notes”), with interest payable on June 30 and December 30 of each year, commencing on December 30, 2020. The Senior Notes are redeemable at the applicable redemption price, subject to the terms described in the indenture for the Senior Notes. However, the Senior Notes may not be redeemed at any time prior to their maturity if enhanced capital requirements, as established by the BMA, would be breached immediately before or after giving effect to the redemption of such notes, unless the Company replaces the capital represented by the Senior Notes to be redeemed with capital having equal or better capital treatment as the notes under applicable BMA rules. The Senior Notes contain covenants, including limitations on liens on the stock of certain designated subsidiaries, limitations on consolidations, mergers, amalgamations and sales of substantially all assets and certain reporting obligations.
The following table sets forth the principal amount of the debt issued as well as the unamortized discount and debt issuance costs at September 30, 2026 and December 31, 2025:
September 30, 2026December 31, 2025
PrincipalUnamortized discount and debt issuance costsPrincipalUnamortized discount and debt issuance costs
7.750% Fixed Rate Reset Subordinated notes due 2055
$400.0 $(6.2)$400.0 $(6.5)
4.875% Senior notes due 2030
330.0 (3.0)330.0 (3.6)
6.625% Fixed Rate Reset Junior Subordinated notes due 2041
— — 125.0 (1.7)
Total
$730.0 $(9.2)$855.0 $(11.8)
11.          Commitments and Contingencies
a.Letter of credit facilities
At September 30, 2026, the Company had the following letter of credit facilities:
September 30, 2026
BankCommitmentIn UseDate of Expiry
Lloyds Bank plc(1)(2)
Unsecured$20.0 $2.9 September 21, 2028
Secured115.0 33.9 September 21, 2028
Total Lloyds Bank plc135.0 36.8 
Citibank N.A. London Branch(1)(2)
Secured70.0 14.2 December 31, 2026
Total Citibank N.A. London Branch70.0 14.2 
Barclays Bank plc(1)(2)
Unsecured20.0 6.7 September 13, 2028
Secured115.0 37.4 September 13, 2028
Total Barclays Bank plc135.0 44.1 
Bank of Montreal(1)(3)
Secured— 1.9 September 18, 2026
Total Bank of Montreal— 1.9 
Total letters of credit facilities$340.0 $97.0 
__________________
(1)Letters of credit can be issued under the secured letter of credit facilities for the purposes of supporting insurance and reinsurance obligations.
(2)The Facility agreements allow for additional capacity in the form of accordions and uncommitted amounts. The maximum additional capacity from the lenders as of September 30, 2026, was: Lloyds Bank plc $65.0 million; Citibank N.A. London Branch $200.0 million; and Barclays Bank plc $65.0 million.
(3)The Company elected not to renew its letter of credit facility with Bank of Montreal, which expired on September 18, 2026. Accordingly, all letters of credit outstanding as of September 18, 2026 were not renewed and will expire in accordance with their respective expiration dates and applicable notice periods. The remaining issuance is fully cash collateralized.
23


The following table shows the value of the collateral underlying the secured letter of credit facilities:
BankSeptember 30,
2026
Lloyds Bank plc$42.5 
Citibank N.A. London branch15.9 
Barclays Bank plc44.4 
Bank of Montreal2.7 
Total$105.5 
The Company's letter of credit facilities are bilateral agreements with one to three year terms. The letters of credit issued under the secured letter of credit facilities are fully collateralized. Each of the above facilities are subject to various affirmative, negative and financial covenants that the Company considers to be customary for such borrowings including certain minimum net worth and maximum debt to capitalization standards.
b.Legal proceedings
Similar to the rest of the insurance and reinsurance industry, the Company is from time to time subject to litigation, arbitration and other dispute resolution proceedings in the ordinary course of its business. Such matters generally arise from questions of insurance or reinsurance coverage, including coverage disputes arising from notable natural catastrophes and man-made loss events, the interpretation or application of policy or contract terms, claims handling activities or the enforcement of the Company’s rights and obligations under insurance or reinsurance agreements, and may involve efforts to collect amounts due to the Company or to defend against claims asserted by policyholders, cedants, reinsurers or other counterparties. The Company may also be involved in the investigation, conduct and defense of other potential litigation, disputes and regulatory or governmental inquiries, including matters relating to underwriting or administrative errors or omissions, employment-related claims or other operational or commercial disputes, from time to time in the ordinary course of business. Pursuant to the Company’s insurance and reinsurance arrangements, a number of these disputes are resolved by arbitration or other forms of alternative dispute resolution, or through negotiated resolution, and the Company considers the status of such matters in establishing its reserves for losses and loss adjustment expenses, as appropriate. The Company is not a party to any litigation or governmental or other proceeding that it believes will have a material impact on the Company’s financial position, results of operations or liquidity.
c.Concentration of credit risk
Credit risk arises out of the failure of a counterparty to perform according to the terms of the contract. The Company underwrites a significant portion of its (re)insurance business through brokers and as a result credit risk exists should any of these brokers be unable to fulfil their contractual obligations with respect to the payments of premium or failure to pass on claims, if there is risk transfer, to the Company. The Company has policies and standards in place to manage and monitor the credit risk of intermediaries with a focus on day-to-day monitoring of the largest positions. Note 9 (Reinsurance and Retrocessional Reinsurance) describes the credit risk related to the Company’s reinsurance recoverables.
12.          Related Party Transactions
On January 3, 2023, The Fidelis Partnership acquired 9.9% of the common shares of the Company. Certain directors, executive officers and management of TFP also own common shares of the Company.
On December 20, 2022, the Company and TFP entered into a rolling 10-year framework agreement (the “Framework Agreement”), effective January 1, 2023, that governs the ongoing relationship between the two groups. Years one to three rolled automatically, whereas from year four onwards, the Framework Agreement will roll at the sole written election of the Company, with such election to be delivered at least 90 days prior to the commencement of the subsequent contract year. Any decision by the Company to elect not to roll the Framework Agreement will mean that the remainder of the 10-year terms then in effect will continue in place. An election to roll the 10 year term of the Framework Agreement was delivered on September 18, 2026.
The underwriting activities of PICB, PICUK and PICI have been primarily outsourced to the corresponding operating subsidiaries of TFP on a jurisdictional basis. TFP manages origination, underwriting, underwriting administration and claims handling under delegated authority agreements with the Company. Other services provided by TFP to the Company include sourcing and administering a portion of the outwards reinsurance program, and support with business planning, capital management, insurance contract accounting and information technology. The Framework Agreement provides for the payment of the following fees with effect from January 1, 2023:
a.Ceding commissions: (i) a ceding commission of 11.5% of net premiums written of open market business procured by The Fidelis Partnership on or after January 1, 2023; (ii) a ceding commission of 3.0% of net premiums written of business sourced by The Fidelis Partnership via third party managing general underwriters on or after January 1, 2023; and (iii) a portfolio management fee of 3.0% of net premiums written of the business sourced by The Fidelis Partnership.
24


b.Profit commission: a profit commission of 20.0% of the aggregate operating profit (defined as underwriting income on business written by The Fidelis Partnership, subject to certain parameters for the allocation of general and administrative expenses, financing costs and other items, and excluding investment income), subject to a hurdle rate of return of 5.0% of underwriting return on equity.
For insurance contracts sourced by The Fidelis Partnership’s Managing General Agent incubator platform, Pine Walk, the fees and commissions follow separately negotiated arrangements and will not attract additional commissions under the terms of the Framework Agreement other than the portfolio management fee of 3.0%.
The following table summarizes The Fidelis Partnership commissions earned, which are included in policy acquisition expenses in the Consolidated Statements of Income:
Three months endedNine months ended
September 30,
2026
September 30, 2025September 30,
2026
September 30, 2025
Ceding commission expense$89.2 $87.1 $244.2 $236.1 
Profit commission expense7.6 — 9.9 — 
The Fidelis Partnership commissions$96.8 $87.1 $254.1 $236.1 
Amounts receivable from TFP at September 30, 2026 of $320.4 million (December 31, 2025: $174.8 million) primarily consist of amounts collected by TFP on behalf of the Company that were not remitted prior to the end of the period. Amounts payable to TFP at September 30, 2026 of $641.9 million (December 31, 2025: $457.7 million) primarily consist of amounts payable to TFP for ceding and profit commissions, and claims paid by TFP on the Company’s behalf.
The Framework Agreement also provides that, in respect of commissions and profit commissions on ceded quota share business, the Company shall retain 1.0% of reinsurance premiums ceded and the remainder is to be paid to TFP. Commissions on ceded business for the three and nine months ended September 30, 2026 of $36.8 million and $90.6 million, respectively (2025: $34.4 million and $89.6 million) were paid to TFP. For the three and nine months ended September 30, 2026 profit commissions on ceded business of $28.2 million and $63.5 million, respectively, (2025: $31.7 million and $15.5 million) were paid to The Fidelis Partnership.
Insurance contracts sourced by Pine Walk contain profit commissions based on the results of each individual contract. The expense for the three and nine months ended September 30, 2026 was $2.7 million and $9.5 million, respectively, (2025: $13.5 million and $46.8 million) and was included within policy acquisition expenses.
TFP provides the Company with certain support services on a cost-plus basis, such as support with business planning, insurance contract accounting and information technology. Included within general and administrative expenses for the three and nine months ended September 30, 2026 are charges of $1.6 million and $3.9 million, respectively, (2025: $1.2 million and $3.0 million) from TFP for such services.
13.          Earnings Per Share
Three months endedNine months ended
September 30,
2026
September 30, 2025September 30,
2026
September 30, 2025
Earnings per common share
Net income$61.7 $130.5 $214.1 $107.7 
Weighted average common shares outstanding81,899,656 104,370,380 86,384,660 108,156,265 
Earnings per common share$0.75 $1.25 $2.48 $1.00 
Earnings per diluted common share
Net income$61.7 $130.5 $214.1 $107.7 
Weighted average common shares outstanding81,899,656 104,370,380 86,384,660 108,156,265 
Share-based compensation plans1,122,539 635,750 777,361 479,643 
Weighted average diluted common shares outstanding83,022,195 105,006,130 87,162,021 108,635,908 
Earnings per diluted common share$0.74 $1.24 $2.46 $0.99 
25


14.          Share Capital Authorized and Issued
The following table sets out the number and par value of shares authorized, issued and outstanding:
September 30,
2026
December 31, 2025
Common shares, par value $0.01 per share
Authorized600,000,000 600,000,000 
Issued and outstanding
Common shares 79,345,285 96,651,534 
Common share dividends
Cash dividends of $0.15 and $0.45 per common share were declared and paid in the three and nine months ended September 30, 2026 (2025: $0.15 and $0.35 per common share).
Common share repurchases
On February 20, 2026, the Board of Directors approved an increase to the current common share repurchase authorization to $400.0 million. Pursuant to the Program, Pelagos may repurchase shares through open market purchases pursuant to Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), accelerated share repurchases or privately negotiated transactions, as well as pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Exchange Act.
The following table summarizes common shares repurchased in the three and nine months ended September 30, 2026 and 2025:
Three months endedNine months ended
September 30,
2026
September 30, 2025September 30,
2026
September 30, 2025
Common shares repurchased3,383,048 1,835,063 17,707,715 8,758,179 
Cost of shares repurchased, inclusive of commissions$83.0 $31.9 $362.5 $142.7 
Weighted average price per share, inclusive of commissions$24.55 $17.40 $20.47 $16.30 
Included in common shares repurchased in the three and nine months ended September 30, 2026 were 1,402,800 and 2,842,800, respectively, common shares repurchased from Pine Brook Feal Intermediate, L.P. for $35.0 million and $66.7 million, respectively, in privately negotiated transactions.
Included in common shares repurchased in the nine months ended September 30, 2026 were 8,597,170 common shares repurchased from CVC Falcon Holdings Limited (“CVC”) for $163.3 million in a privately negotiated transaction. Following this transaction, CVC no longer holds any ownership interest in Pelagos.
Included in common shares repurchased in the three and nine months ended September 30, 2026, were 334,085 and 1,709,032, respectively, (2025: 180,071 and 857,794) common shares repurchased from TFP for $8.2 million and $35.0 million, respectively, (2025: $3.1 million and $14.0 million). These transactions were effected at a price equal to the average price paid by the Company on such day for share repurchases from all other shareholders. The repurchase mechanism follows a prescribed format designed to keep TFP’s ownership of PLGO to below 9.8752%.
Common shares repurchased by the Company are retired. The unutilized amount of the share repurchase authorization at September 30, 2026 was $56.1 million.
15.          Income Taxes
The Company’s income tax expense for the three and nine months ended September 30, 2026, resulted in an effective tax rate of 16.0% and 6.7%, respectively, (2025: 18.8% and 18.8%). The income tax expense for the three and nine months ended September 30, 2026 was $11.7 million and $15.3 million, respectively, (2025: $30.3 million and $25.0 million).
In December 2025, in response to updated guidance from the Organisation for Economic Co-operation and Development (“OECD”), an amendment to the Bermuda Corporate Income Taxes Act was enacted. The amendment eliminated reductions to the tax basis recognized as part of the Economic Transition Adjustment in 2023 and resulted in a deferred tax benefit of $23.5 million in the year ended December 31, 2025.
At December 31, 2025, the U.K. had not enacted legislation which implemented that OECD guidance. Accordingly, a Pillar 2 top-up tax charge of $21.4 million was accrued in the year ended December 31, 2025. The U.K. Finance Act 2026 was enacted in March 2026, implementing the OECD guidance. Therefore, the U.K. top-up tax liability of $21.4 million has been released in the three months ended March 31, 2026 and treated as a discrete period benefit.
26


The Company’s income tax expense may fluctuate from period to period based on the relative mix of income or loss reported by jurisdiction and the varying tax rates in each jurisdiction.
16.          Subsequent Events
Share repurchases
On November 3, 2026, the Company's Board of Directors approved the replenishment of the Company's authorization under its share repurchase program (the “Program”), bringing the total current authorization to $400.0 million. Pursuant to the Program, PLGO may repurchase shares through open market purchases pursuant to Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), accelerated share repurchases or privately negotiated transactions, as well as pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Exchange Act.
Dividends
On November 3, 2026, the Company’s Board of Directors announced (i) an increase to the existing dividend program under which PLGO intends to pay a quarterly cash dividend of $0.22 and (ii), pursuant to that plan that it had approved and declared a dividend of $0.22 per share payable on December 23, 2026, to common shareholders of record on December 11, 2026.
27


Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following is a discussion and analysis of our results of operations for the three and nine months ended September 30, 2026 and 2025 and our financial condition at September 30, 2026. This discussion and analysis should be read in conjunction with our audited and unaudited consolidated financial statements for those respective periods and related notes contained therein. This discussion and analysis contains forward-looking statements, which are subject to known and unknown risks and uncertainties, many of which may be beyond the Company’s control that could cause the Company’s actual results to differ materially from those projected, anticipated or implied. The most significant of these risks and uncertainties are described in Item 3.D, “Risk Factors” contained in the Company’s Annual Report on Form 20-F for the year ended December 31, 2025, as filed with the Securities and Exchange Commission on March 5, 2026. On May 11, 2026, the Company’s legal name change from Fidelis Insurance Holdings Limited to Pelagos Insurance Capital Limited took effect. The terms “we,” “our,” “us,” “Pelagos,” “Pelagos Insurance Capital,” and the “Company,” as used herein, refer to Pelagos Insurance Capital Limited and legacy Fidelis Insurance Holdings Limited and its subsidiaries as a combined entity, unless otherwise indicated. TFP Intermediate Holdings II Limited is the parent company of an external managing general underwriting platform known as “The Fidelis Partnership” or “TFP.”
Tabular amounts are in U.S. Dollars in millions, except for share and per share amounts, unless otherwise noted.
Overview
Pelagos Insurance Capital is a strategic capital allocator and risk selector in specialty insurance and reinsurance, focused on identifying the most compelling opportunities in the market to allocate capital and the best-in-class partners to execute the Company’s underwriting strategy in those areas.
The Company was formed under the principles of focused, process-driven and disciplined underwriting and risk selection, strong client and broker relationships and nimble capital deployment. The Company, originally founded as Fidelis Insurance Holdings Limited and known as “Fidelis” prior to the Separation Transactions, completed its initial funding and began underwriting business in June 2015 under the direction of an innovative and experienced management team.
The Company comprises Pelagos Insurance Capital Limited (formerly known as Fidelis Insurance Holdings Limited or “FIHL”) and its principal operating insurance subsidiaries Pelagos Insurance Capital Bermuda Limited (formerly known as Fidelis Insurance Bermuda Limited or “FIBL”) (“PICB”), Pelagos Insurance Capital Underwriting Limited (formerly known as Fidelis Underwriting Limited or “FUL”) (“PICUK”), and Pelagos Insurance Capital Ireland DAC (formerly known as Fidelis Insurance Ireland DAC or “FIID”) (“PICI”) and has its own service company, Pelagos (UK) Services Limited with a branch in Ireland (formerly known as FIHL (UK) Services Limited or “FSL”) (“PSL”). In 2024 the Company established Nameco (No 1404) Limited (the “Pelagos Corporate Member”), which has a 7.4% participation in the 2026 year of account of Lloyd’s Syndicate 3123 (2025 year of account: 7.4%). Starting on January 1, 2026, we also began participating in the underwriting activity of other Lloyd’s Syndicates.
Our business comprises two segments: Insurance and Reinsurance, with a diversified portfolio spanning 10 lines of business. This breadth allows us to provide solutions for customers across a broad range of industries, manage different types of risk, and operate effectively across geographic regions. Our disciplined underwriting and active capital management enable us to respond dynamically to market cycles and pursue opportunities that we believe offer an attractive balance of risk and return.
The Insurance segment comprises a portfolio of specialty risks. In addition to major specialty lines of business, this segment includes highly tailored products, where the buying motivation is often driven by regulatory capital relief, capital efficiency or transaction facilitation. The lines of business within this segment are Property, Marine, Asset Backed Finance & Portfolio Credit, Energy, Cyber, Aviation & Aerospace, Political Risk, Violence & Terror, and Other Insurance risks. A strong rating environment following years of compound rate increases across multiple business lines within the Insurance segment have provided opportunities for targeted growth. We leverage our lead position to cross-sell across our portfolio and achieve preferential terms and conditions. This, combined with long established relationships, has enabled Pelagos Insurance Capital to build an established book of specialty business. Given the market environment we have increasingly used our Insurance segment to deploy capital targeted to natural catastrophe exposure through the Property line of business. This allows a more selective approach to managing aggregate exposure.
Our Reinsurance segment consists of an actively managed global, property reinsurance portfolio, providing reinsurance and a limited amount of retrocession coverage on both a proportional and excess of loss basis.
Our strategic objectives focus on the following:
•Building a scalable, high-quality underwriting portfolio that generates attractive risk-adjusted returns across market cycles;
•Generating sustainable long-term shareholder value through disciplined capital allocation;
•Maintaining effective organizational structures, governance, and operational capabilities to support strategic execution; and
•Promoting a performance-driven, collaborative culture that attracts, develops, and retains talent.
28


Financial Highlights
The following table details the key items discussed in the consolidated results of operations section and key financial indicators in evaluating our performance for the three and nine months ended September 30, 2026 and 2025:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net income$61.7 $130.5 $214.1 $107.7 
Operating net income(1)
83.3 126.8 200.4 95.2 
Gross premiums written839.8 797.5 3,977.0 3,739.4 
Net premiums earned783.7 599.8 1,933.3 1,740.8 
Catastrophe and large losses115.9 57.4 350.0 465.0 
Net favorable/(adverse) prior year reserve development(4.7)16.0 31.1 (32.4)
Net investment income44.6 45.9 132.3 140.0 
Net realized and unrealized investment gains/(losses)$(27.4)$6.2 $(4.1)$18.8 
Combined ratio91.5%79.0%92.4%99.5%
Annualized return on average common equity11.3%22.0%12.6%5.9%
Annualized Operating ROAE(1)
15.3%21.4%11.8%5.2%
Earnings per diluted common share0.74 1.24 $2.46 $0.99 
Operating EPS(1)
1.00 1.21 $2.30 $0.88 
__________________
(1)    See definition and reconciliation of these non-GAAP financial measures in “Performance Measures and Non-GAAP Financial Measures”.
Pelagos’ Third Quarter in Review for 2026
For the three months ended September 30, 2026, gross premiums written (“GPW”) increased to $839.8 million, or 5.3% above the prior year period. Net income for the third quarter of 2026 was $61.7 million, or $0.74 per diluted common share. Operating net income for the third quarter of 2026 was $83.3 million, or $1.00 per diluted common share. Our combined ratio was 91.5% for the three months ended September 30, 2026, compared to 79.0% in the prior year period. Our Annualized Operating ROAE was 15.3% in the three months ended September 30, 2026.
The first nine months of 2026 saw continued growth in our gross premiums written to $4.0 billion, or 6.4% above the prior year period. Our combined ratio was 92.4% for the nine months ended September 30, 2026, compared to 99.5% in the prior year period. The improvement was primarily a result of lower catastrophe and large losses of $350.0 million in the nine months ended September 30, 2026, compared to $465.0 million in the prior year period, which were primarily driven by the California wildfires. Our Annualized Operating ROAE was 11.8% in the nine months ended September 30, 2026, compared with 5.2% in the prior year period. During the nine months ended September 30, 2026, we repurchased 17,707,715 common shares for $362.5 million, including commission expense, at a weighted average cost per share of $20.47, including commission expenses. Book value per diluted common share was $26.60 at September 30, 2026, an increase of 8.1% from December 31, 2025, of $24.61.
Recent Developments
Pelagos Insurance Capital (formerly Fidelis Insurance Group) Rebrand
Following shareholder approval at the Annual General Meeting on April 28, 2026, Fidelis Insurance Group has rebranded as Pelagos Insurance Capital, effective May 11, 2026. The legal name change became effective on the same date and the Company began trading on the New York Stock Exchange under its new name and ticker symbol, “PLGO,” on May 12, 2026.
Market Update
Our capital allocator model, diversified portfolio and underwriting partnerships are designed to provide flexibility in responding to changing market conditions while maintaining a focus on underwriting profitability. Market conditions remained competitive during the quarter, as increased industry capacity and market dynamics contributed to continued pricing pressure in certain insurance and reinsurance markets, including areas of property, while selected specialty lines continued to exhibit more favorable underwriting conditions. In this environment, we remained focused on disciplined underwriting and selective capital deployment, adjusting our portfolio to reflect prevailing market conditions and expected risk-adjusted returns.
Performance Measures and Non-GAAP Financial Measures
In presenting our results, we have included certain non-GAAP financial measures that we believe are useful to consider, in addition to our U.S. GAAP results, for a more complete understanding of the financial performance and position of PLGO. The key performance
29


measures and non-GAAP financial measures that we believe are meaningful in analyzing our performance are summarized below and where applicable a reconciliation of non-GAAP financial measures to U.S. GAAP financials is set out. However, any non-GAAP financial measures should not be viewed as a substitute for those determined in accordance with U.S. GAAP and our methodology for calculating these measures may be different from the way our industry peers calculate these measures.
Underwriting Performance Measures
The table below reconciles our attritional and catastrophe and large loss ratios to losses and loss adjustment expenses, loss ratio, underwriting ratio and combined ratio for the three and nine months ended September 30, 2026 and 2025:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net premiums earned
$783.7 $599.8 $1,933.3 $1,740.8 
Attritional losses231.3 139.3 549.4 409.2 
Catastrophe and large losses115.9 57.4 350.0 465.0 
Prior year (favorable)/ adverse development4.7 (16.0)(31.1)32.4 
Losses and loss adjustment expenses
351.9 180.7 868.3 906.6 
Policy acquisition expenses (third party) 238.5 179.3 576.9 516.2 
The Fidelis Partnership commissions(1)
96.8 87.1 254.1 236.1 
General and administrative expenses$29.5 $27.2 $88.0 $71.5 
Attritional loss ratio
29.5%23.2%28.4%23.5%
Catastrophe and large loss ratio
14.8%9.6%18.1%26.7%
Prior year loss reserve development impact on loss ratio0.6%(2.7%)(1.6%)1.9%
Loss ratio
44.9%30.1%44.9%52.1%
Policy acquisition expenses ratio30.4%29.9%29.8%29.7%
Underwriting ratio 75.3%60.0%74.7%81.8%
The Fidelis Partnership commissions ratio12.4%14.5%13.1%13.6%
General and administrative expenses ratio3.8%4.5%4.6%4.1%
Combined ratio 91.5%79.0%92.4%99.5%
_________________
(1)     Included in policy acquisition expenses on the Consolidated Statements of Income. For further details, see Note 12 (Related Party Transactions) of our unaudited consolidated financial statements.
•Loss ratio: is calculated by dividing losses and loss adjustment expenses by net premiums earned (“NPE”). The losses will be affected by the occurrence and frequency of catastrophe events, the volume and severity of non-catastrophe losses and the extent of any outwards reinsurance that mitigates the effect of those losses.
•Attritional loss ratio and catastrophe and large loss ratio: the attritional loss ratio is a non-GAAP measure of the loss ratio excluding the impact of catastrophe and large losses. Management believes that the attritional loss ratio is a performance measure that is useful to investors as it excludes losses that are not as predictable as to timing and amount. The attritional loss ratio is calculated by dividing the losses and loss adjustment expenses, excluding catastrophe and large losses and prior year development, by NPE. The catastrophe and large loss ratio is a non-GAAP measure that is calculated by dividing the current year catastrophe and large loss expense by NPE.
•Underwriting ratio: is calculated by dividing losses and loss adjustment expenses and policy acquisition expenses (excluding TFP commissions) by NPE, or equivalently, by adding the loss ratio and policy acquisition expense ratio (excluding TFP commissions).
•Combined ratio: is calculated by dividing losses and loss adjustment expenses, policy acquisition expenses and general and administrative expenses by NPE, or equivalently, by adding the loss ratio, policy acquisition expense ratio, The Fidelis Partnership commissions ratio and general and administrative expense ratio. A combined ratio under 100% indicates an underwriting profit, while a combined ratio over 100% indicates an underwriting loss.
30


Investment Performance Measures
The table below sets out the calculations of our investment performance measures for the three and nine months ended September 30, 2026 and 2025:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net investment income$44.6 $45.9 $132.3 $140.0 
Net realized and unrealized gains/(losses) on other investments(9.0)4.7 17.9 10.4 
Net realized and unrealized investment gains/(losses) excluding other investments(18.4)1.5 (22.0)8.4 
Net investment return
17.2 52.1 128.2 158.8 
Opening
Total investments3,775.0 3,154.2 3,237.4 3,834.7 
Cash and cash equivalents and restricted cash and cash equivalents517.1 1,103.5 1,247.6 946.6 
Derivative assets, at fair value— — 2.4 — 
Accrued investment income29.4 28.7 28.3 35.3 
Investment assets pending settlement7.1 30.2 4.8 0.5 
Derivative liabilities, at fair value(1.6)(4.3)(1.7)(0.5)
Investment liabilities pending settlement(17.4)(5.4)(6.6)(21.1)
Net investable assets4,309.6 4,306.9 4,512.2 4,795.5 
Closing
Total investments3,722.9 3,295.8 3,722.9 3,295.8 
Cash and cash equivalents and restricted cash and cash equivalents526.3 1,089.0 526.3 1,089.0 
Derivative assets, at fair value0.3 0.2 0.3 0.2 
Accrued investment income24.9 23.9 24.9 23.9 
Investment assets pending settlement19.5 4.6 19.5 4.6 
Derivative liabilities, at fair value— (0.1)— (0.1)
Investment liabilities pending settlement(21.3)(10.6)(21.3)(10.6)
Net investable assets4,272.6 4,402.8 4,272.6 4,402.8 
Average investable assets
$4,291.1 $4,354.9 $4,392.4 $4,599.2 
Net investment return - annualized1.6%4.8%3.9%4.6%
•Net investment return percentage: is calculated as annualized net investment return divided by total average investable assets (including cash and cash equivalents and restricted cash and cash equivalents).


31


Operating Performance Measures
The table below sets out the calculation of our operating performance measures for the three and nine months ended September 30, 2026 and 2025:
Three months endedNine months ended
($ in millions except for share and per share amounts)September 30,
2026
September 30, 2025September 30,
2026
September 30, 2025
Net income$61.7 $130.5 $214.1 $107.7 
Adjustment for net realized and unrealized investment (gains)/losses27.4 (6.2)4.1 (18.8)
Adjustment for net foreign exchange (gains)/losses(2.0)1.7 2.0 2.2 
Adjustment for corporate and other expenses0.3 — 3.0 1.2 
Income tax (benefit)/expense (1)
(4.1)0.8 (22.8)2.9 
Operating net income$83.3 $126.8 $200.4 $95.2 
Average common shareholders' equity$2,180.9 $2,369.8 $2,270.4 $2,432.3 
Weighted average common shares outstanding81,899,656 104,370,380 86,384,660 108,156,265 
Share-based compensation plans1,122,539 635,750 777,361 479,643 
Weighted average diluted common shares outstanding83,022,195 105,006,130 87,162,021 108,635,908 
Annualized ROAE11.3 %22.0 %12.6 %5.9 %
Annualized Operating ROAE15.3 %21.4 %11.8 %5.2 %
Earnings per diluted common share$0.74 $1.24 $2.46 $0.99 
Operating EPS$1.00 $1.21 $2.30 $0.88 
_________________
(1)     Income tax (benefit)/expense on adjustments to net income/(loss). The income tax benefit for the nine months ended September 30, 2026 includes the reversal of a U.K. top-up tax charge of $21.4 million, see Note 15 (Income Taxes) of our unaudited consolidated financial statements.
•Operating net income: is a non-GAAP financial measure of our performance which does not consider the impact of certain non-recurring and other items that may not properly reflect the ordinary activities of our business, its performance or its future outlook. This measure is calculated as net income excluding net realized and unrealized investment gains/(losses), net foreign exchange gains/(losses), corporate and other expenses, and the income tax effect on these items.
•Annualized return on average common equity (“Annualized ROAE”): represents annualized net income divided by average common shareholders’ equity.
•Annualized operating return on average common equity (“Annualized Operating ROAE”): is a non-GAAP financial measure that represents a meaningful comparison between periods of our financial performance expressed as a percentage and is calculated as annualized operating net income divided by average common shareholders’ equity.
•Operating earnings per share (“Operating EPS”): is a non-GAAP financial measure that represents a valuable measure of profitability and enables investors, analysts, rating agencies and other users of our financial information to more easily analyze our results in a manner similar to how management analyzes its underlying business performance. It is calculated by dividing operating net income by the weighted average diluted common shares outstanding.
32


Results of Operations
The following table sets forth the key items discussed in the consolidated results of operations section, and the period over period change, for the three and nine months ended September 30, 2026 and 2025:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
Underwriting income$67.0 $125.5 $(58.5)$146.0 $10.4 $135.6 
Net investment income44.6 45.9 (1.3)132.3 140.0 (7.7)
Net realized and unrealized investment gains/(losses)(27.4)6.2 (33.6)(4.1)18.8 (22.9)
Corporate and other expenses(0.3)— (0.3)(3.0)(1.2)(1.8)
Net foreign exchange gains/(losses)2.0 (1.7)3.7 (2.0)(2.2)0.2 
Financing costs(12.5)(15.1)2.6 (39.8)(33.1)(6.7)
Income tax expense(11.7)(30.3)18.6 (15.3)(25.0)9.7 
Net income$61.7 $130.5 $(68.8)$214.1 $107.7 $106.4 
Underwriting Results by Segment
We classify our business into two segments: Insurance and Reinsurance.
The Insurance segment is comprised of a portfolio of Property, Marine, Asset Backed Finance & Portfolio Credit, Energy, Cyber, Aviation & Aerospace, Political Risk, Violence & Terror, and Other Insurance risks.
The Reinsurance segment is primarily a property catastrophe book, with a smaller proportion of Retro & Whole Account business.
Insurance Segment
The following table is a summary of our Insurance segment’s underwriting results:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
Gross premiums written$686.1 $605.8 $80.3 $3,035.7 $2,775.1 $260.6 
Reinsurance premium ceded(165.6)(217.3)51.7 (967.7)(1,031.5)63.8 
Net premiums written520.5 388.5 132.0 2,068.0 1,743.6 324.4 
Net premiums earned634.0 456.5 177.5 1,663.6 1,427.3 236.3 
Losses and loss adjustment expenses(341.6)(177.0)(164.6)(870.6)(750.2)(120.4)
Policy acquisition expenses(193.8)(137.2)(56.6)(496.9)(434.3)(62.6)
Underwriting income$98.6 $142.3 $(43.7)$296.1 $242.8 $53.3 
Loss ratio53.9 %38.8 %15.1 pts52.3 %52.6 %(0.3) pts
Policy acquisition expense ratio30.6 %30.1 %0.5 pts29.9 %30.4 %(0.5) pts
Underwriting ratio84.5 %68.9 %15.6 pts82.2 %83.0 %(0.8) pts
For the three months ended September 30, 2026, our GPW increased primarily driven by growth from our Other Insurance and Marine lines of business. For the nine months ended September 30, 2026, our GPW increased primarily driven by growth from our network of expanded underwriting partners, in several lines of business, partially offset by a non-renewal in our Cyber line of business that did not meet our underwriting criteria and rating hurdles.
For the three and nine months ended September 30, 2026, net premiums earned ("NPE") increased due to earnings from higher net premiums written in the current and prior year periods, and as a result of higher gross premiums written in our Marine line of business.
Our policy acquisition expense ratio for the three and nine months ended September 30, 2026 remained consistent with the prior year periods.
33


The following table is a summary of our Insurance segment’s losses and loss adjustment expenses:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
Attritional losses$206.6 $121.5 $85.1 $512.3 $365.3 $147.0 
Catastrophe and large losses119.2 58.2 61.0 348.0 281.7 66.3 
(Favorable)/adverse prior year development15.8 (2.7)18.5 10.3 103.2 (92.9)
Losses and loss adjustment expenses$341.6 $177.0 $164.6 $870.6 $750.2 $120.4 
Loss ratio - attritional losses32.6 %26.6 %6.0 pts30.8 %25.6 %5.2 pts
Loss ratio - catastrophe and large losses18.8 %12.8 %6.0 pts20.9 %19.8 %1.1 pts
Loss ratio - prior accident years2.5 %(0.6)%3.1 pts0.6 %7.2 %(6.6) pts
Loss ratio53.9 %38.8 %15.1 pts52.3 %52.6 %(0.3) pts
For the three months ended September 30, 2026, our loss ratio in the Insurance segment increased by 15.1 points compared to the prior year period. For the nine months ended September 30, 2026, our loss ratio in the Insurance segment improved by 0.3 points compared to the prior year period.
The attritional loss ratio for the three and nine months ended September 30, 2026, increased by 6.0 points and 5.2 points, respectively, compared to the prior year periods due to the prior year periods being benign in terms of attritional losses.
The catastrophe and large losses for the three months ended September 30, 2026, were primarily attributable to losses related to the conflicts in the Black Sea and the Middle East in our Marine line of business. This compared to the prior period catastrophe and large losses that were primarily attributable to two loss events in our Property and Other Insurance lines of business. The catastrophe and large losses for the nine months ended September 30, 2026 were primarily attributable to losses related to the conflicts in the Middle East and the Black Sea, the gas plant explosion at the Ras Laffan facility in Qatar, as well as loss events in various lines of business including Other Insurance, Property and Marine. This compared to the prior period catastrophe and large losses that were primarily attributable to the California wildfires in our Property line of business, together with other losses in our Other Insurance, Aviation & Aerospace, and Property lines of business.
For the three months ended September 30, 2026, adverse prior year development was primarily driven by our Political Risk, Violence and Terror line of business, partially offset by better than expected loss emergence in multiple lines of business. For the nine months ended September 30, 2026, adverse prior year development was primarily driven by increased loss estimates related to the Baltimore Bridge collapse within our Marine line of business, as well as increased loss estimates in our Political Risk, Violence and Terror line of business and increases in prior year property D&F losses. These increases were partially offset by better than expected loss emergence in multiple lines of business.
Reinsurance Segment
The following table is a summary of our Reinsurance segment’s underwriting results:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
Gross premiums written$153.7 $191.7 $(38.0)$941.3 $964.3 $(23.0)
Reinsurance premium ceded(81.9)(76.0)(5.9)(467.5)(478.4)10.9 
Net premiums written71.8 115.7 (43.9)473.8 485.9 (12.1)
Net premiums earned149.7 143.3 6.4 269.7 313.5 (43.8)
Losses and loss adjustment expenses(10.3)(3.7)(6.6)2.3 (156.4)158.7 
Policy acquisition expenses(44.7)(42.1)(2.6)(80.0)(81.9)1.9 
Underwriting income$94.7 $97.5 $(2.8)$192.0 $75.2 $116.8 
Loss ratio6.9 %2.6 %4.3 pts(0.9)%49.9 %(50.8) pts
Policy acquisition expense ratio29.9 %29.4 %0.5 pts29.7 %26.1 %3.6 pts
Underwriting ratio36.8 %32.0 %4.8 pts28.8 %76.0 %(47.2) pts
For the three months ended September 30, 2026, GPW decreased compared to the prior year period, primarily due to the restructuring of a client's program. For the nine months ended September 30, 2026, our GPW decreased primarily from reinstatement premiums related to the California wildfires in the prior year period and the restructuring of a client's program. The decrease was partially offset by targeted deployment into areas where we continue to see attractive risk-adjusted returns.
34


For the three months ended September 30, 2026, NPE increased driven by our expanded network of underwriting partners and business mix. For the nine months ended September 30, 2026, NPE decreased due to the acceleration of earnings on contracts with exposure to the California wildfires in the prior year period and changes in our business mix.
Our policy acquisition expense ratio for the three and nine months ended September 30, 2026 increased primarily due to business mix and changes in ceded premium and commissions earned from outwards reinsurance partners.
The following table is a summary of our Reinsurance segment’s losses and loss adjustment expenses:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
Attritional losses$24.7 $17.8 $6.9 $37.1 $43.9 $(6.8)
Catastrophe and large losses(3.3)(0.8)(2.5)2.0 183.3 (181.3)
Favorable prior year development(11.1)(13.3)2.2 (41.4)(70.8)29.4 
Losses and loss adjustment expenses$10.3 $3.7 $6.6 $(2.3)$156.4 $(158.7)
Loss ratio - attritional losses16.5 %12.5 %4.0 pts13.8 %14.0 %(0.2) pts
Loss ratio - catastrophe and large losses(2.2)%(0.6)%(1.6) pts0.7 %58.5 %(57.8) pts
Loss ratio - prior accident years(7.4)%(9.3)%1.9 pts(15.4)%(22.6)%7.2 pts
Loss ratio6.9 %2.6 %4.3 pts(0.9)%49.9 %(50.8) pts
For the three months ended September 30, 2026, our loss ratio in the Reinsurance segment increased by 4.3 points compared to the prior year period. For the nine months ended September 30, 2026, our loss ratio in the Reinsurance segment improved by 50.8 points compared to the prior year period.
The attritional loss ratio for the three months ended September 30, 2026, increased by 4.0 points compared to the prior year period, both of which were benign in terms of attritional losses. The attritional loss ratio for the nine months ended September 30, 2026, remained consistent with the prior year period.
There were no material catastrophe and large losses for the three and nine months ended September 30, 2026. There were no material catastrophe and large losses for the three months ended September 30, 2025. The catastrophe and large losses for the nine months ended September 30, 2025 were attributable to the California wildfires.
For the three and nine months ended September 30, 2026, favorable prior year development was driven by positive development on catastrophe losses and benign prior year attritional experience.
Other Underwriting Expenses
We do not allocate The Fidelis Partnership commissions or general and administrative expenses by segment.
The Fidelis Partnership Commissions
The Fidelis Partnership manages origination, underwriting, underwriting administration, outwards reinsurance and claims handling under delegated authority agreements with the Company. The following table summarizes The Fidelis Partnership commissions earned:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
Ceding commission expense$89.2 $87.1 $2.1 $244.2 $236.1 $8.1 
Profit commission expense7.6 — 7.6 9.9 — 9.9 
The Fidelis Partnership commissions$96.8 $87.1 $9.7 $254.1 $236.1 $18.0 
Ceding commission expense ratio11.4 %14.5 %(3.1) pts12.6 %13.6 %(1.0) pts
Profit commission expense ratio1.0 %— %1.0 pts0.5 %— %0.5 pts
The Fidelis Partnership commissions ratio12.4 %14.5 %(2.1) pts13.1 %13.6 %(0.5) pts
For the three and nine months ended September 30, 2026, the decrease in The Fidelis Partnership commissions ratio was driven by our business mix, partially offset by the increase of the accrued profit commission as a result of operating profit in the periods. For further details, see Note 12 (Related Party Transactions) of our unaudited consolidated financial statements.
35


General and Administrative Expenses
For the three and nine months ended September 30, 2026, general and administrative expenses were $29.5 million and $88.0 million, respectively (2025: $27.2 million and $71.5 million, respectively). The increase was due to strategic investments to strengthen our talent base, enhance our infrastructure and improve our technology. Also, improved financial performance resulted in higher variable compensation accruals in the current year.
Investments
The components of net investment return are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
20262025Change20262025Change
Net investment income$44.6 $45.9 $(1.3)$132.3 $140.0 $(7.7)
Net realized and unrealized gains/(losses) on other investments(9.0)4.7 (13.7)17.9 10.4 7.5 
Net realized and unrealized investment gains/(losses) excluding other investments(18.4)1.5 (19.9)(22.0)8.4 (30.4)
Net investment return
$17.2 $52.1 $(34.9)$128.2 $158.8 $(30.6)
Net Investment Income
Net investment income is the interest income earned on our cash balances, available-for-sale (AFS) fixed income securities and distributions received from our fixed income funds and private credit funds, net of total investment expenses. For the three and nine months ended September 30, 2026, we generated net investment income of $44.6 million and $132.3 million, respectively, at an average annualized yield of 4.6% and 4.3%, respectively (2025: $45.9 million and $140.0 million at an average annualized yield of 4.5% and 4.4%). The decrease in our net investment income for the three months ended September 30, 2026, was driven by lower investable assets compared to the prior year period. For the nine months ended September 30, 2026, the decrease was primarily driven by lower investable assets compared to the prior year period.
Net Realized and Unrealized Gains/(Losses) on Other Investments
Net realized and unrealized gains/(losses) on other investments is the change in net asset value ("NAV") of our fixed income fund, hedge fund and private credit fund investments. The decrease for the three months ended September 30, 2026, was driven by a negative change in the NAV on our fixed income funds as interest rates moved higher in the quarter and by a negative performance from our hedge fund portfolio. For the nine months ended September 30, 2026, the increase was driven by positive performance from our hedge fund portfolio, partially offset by a negative change in the NAV on our fixed income funds as interest rates moved higher in the year.
Net Realized and Unrealized Investment Gains/(Losses) Excluding Other Investments
Net realized and unrealized investment gains/(losses) excluding other investments includes net realized gains/(losses) on sales of fixed maturity securities, available-for-sale, and movements in our provision for current expected credit losses. For the three and nine months ended September 30, 2026, the decrease resulted primarily from movements in our provision for current expected credit losses of $(15.7) million and $(18.7) million, respectively (2025: $0.3 million and $5.6 million).
Corporate and Other Expenses
Corporate and other expenses in the three and nine months ended September 30, 2026 include unamortized discount and debt issuance costs on the redemption of junior notes and expenses related to our rebrand.
Net Foreign Exchange Gains/(Losses)
At September 30, 2026, we held foreign exchange contracts with a notional amount of $79.7 million (December 31, 2025: $133.3 million). These contracts are used to manage foreign currency risks in our underwriting and non-investment operations. The foreign exchange contracts were recorded as derivatives at fair value in the Consolidated Balance Sheets with changes recorded as net foreign exchange gains and losses in the Consolidated Statements of Income.
Financing Costs
For the three and nine months ended September 30, 2026, financing costs were $12.5 million and $39.8 million, respectively (2025: $15.1 million and $33.1 million, respectively). For the three months ended September 30, 2026, our financing costs decreased as our debt level decreased in April 2026. For the nine months ended September 30, 2026, our financing costs increased as our debt level increased in June 2025. For further details related to the debt issuance, see Note 10 (Long Term Debt) of our unaudited consolidated
36


financial statements. Also included in financing costs are costs associated with our letter of credit facilities as discussed in Note 11a (Commitments and Contingencies - Letter of Credit Facilities) of our unaudited consolidated financial statements.
Financial Condition, Liquidity and Capital Resources
Financial Condition at September 30, 2026
•Total cash and cash equivalents, restricted cash and cash equivalents, and investments of $4.2 billion. 90.9% is comprised of cash and cash equivalents, restricted cash and cash equivalents, fixed maturities, short-term securities and fixed income funds.
•The average duration of the available-for-sale fixed income portfolio was 3.0 years.
•Total long-term debt of $720.8 million, resulting in a debt-to-total capital ratio of 25.2%.
•Total capital of $2.9 billion, with $400.5 million of capital returned to common shareholders in the nine months ended September 30, 2026, including common share repurchases of $362.5 million and dividends of $38.0 million.
•Book value per diluted common share of $26.60 (dilutive shares at September 30, 2026 of 1,164,367).
Liquidity
Liquidity is a measure of a company’s ability to generate cash flows sufficient to meet short-term and long-term cash requirements of its business operations. Management monitors the liquidity of PLGO and each of our operating insurance subsidiaries. As a Bermuda holding company, PLGO relies on dividends and other distributions from its operating subsidiaries to provide cash flow to meet ongoing cash requirements, including principal and interest payments on our debt and other expenses, tax expenses, the repurchase of common shares, and dividends to the holders of our common shares.
The payment of dividends by our subsidiaries is, under certain circumstances, limited by the applicable laws and regulations in the various jurisdictions in which our subsidiaries operate. In addition, insurance laws require our insurance subsidiaries to maintain certain measures of solvency and liquidity. We believe that each of our insurance subsidiaries and branches exceeded the minimum solvency, capital and surplus requirements in their applicable jurisdictions at September 30, 2026.
During the nine months ended September 30, 2026, PLGO received dividends from subsidiaries of $425.0 million.
Management considers the current cash and cash equivalents, together with dividends declared or expected to be declared by the operating insurance subsidiaries, sufficient to appropriately satisfy the liquidity requirements of PLGO.
Capital Resources
We maintain our capital at an appropriate level as determined by our Company Board-approved internal risk appetite and the financial strength required by our clients, regulators and rating agencies. We monitor and review the capital and liquidity positions of PLGO and its operating insurance subsidiaries on an ongoing basis.
The principal capital transactions related to our common shares undertaken during the nine months ended September 30, 2026 were:
•Repurchase of common shares: Repurchases of an aggregate of 17,707,715 common shares for an aggregate of $362.4 million, excluding expenses, pursuant to the Company’s share repurchase program (see Note 14 (Share Capital Authorized and Issued) of our unaudited consolidated financial statements). On November 3, 2026, we announced that our Board of Directors approved a renewal to the current share repurchase program, bringing the total current authorization to $400.0 million.
•Dividend payments to the common shareholders: During the nine months ended September 30, 2026, we paid quarterly cash dividends to our common shareholders for a total dividend distribution of $38.0 million (2025: $37.4 million).
Long-term debt: At September 30, 2026, PLGO had $720.8 million in debt outstanding. For the nine months ended September 30, 2026, PLGO incurred interest expense of $37.7 million on outstanding debt. Such debt was comprised of the Senior Notes and the Subordinated Notes. In April 2026, the Company redeemed its Junior Notes for their principal amount of $125.0 million, plus accrued and unpaid interest up to the redemption date.
Access to capital: Our business operations are in part dependent on our financial strength and the opinions of the independent rating agencies thereof. We believe our financial strength provides us with the flexibility and capacity to obtain funds through debt or equity financing as required from the public and private markets. Our ability to access the capital markets is dependent on, among other things, our operating results, market conditions, and our perceived financial strength. We regularly monitor our capital and financial position, as well as investment and securities market conditions.
37


Ratings: Our financial strength ratings as determined by AM Best, Standard & Poor’s and Moody’s provide an independent assessment of our financial strength and ability to meet policyholder obligations. There have been no material changes to our financial strength ratings during the nine months ended September 30, 2026.
Inflation: We consider the effects of inflation in pricing our contracts and policies through modeled components such as demand surge. Loss reserves are established to recognize likely loss settlements at the date payment is made. Those reserves inherently recognize the effects of inflation. The actual effects of inflation on our results cannot be accurately known, however, until claims are ultimately resolved.
Cash Flows
The following table summarizes our cash flows from operating, investing and financing activities:
Nine Months Ended
September 30,
2026
September 30, 2025
Net cash provided by/(used in) operating activities$381.5 $(637.1)
Net cash provided by/(used in) investing activities(573.1)618.2 
Net cash provided by/(used in) financing activities(527.2)153.4 
Effect of exchange rate changes on foreign currency cash(2.5)7.9 
Net increase/(decrease) in cash, restricted cash, and cash equivalents$(721.3)$142.4 
Cash flows provided by operating activities can fluctuate due to timing differences between the collection of premiums and reinsurance recoverables, the payment of losses and loss adjustment expenses, the payment of premiums to outward reinsurers and operating expenses. The net operating cash inflows, for the nine months ended September 30, 2026, primarily related to premium receipts, outwards reinsurance recoveries and interest income exceeding payments for claims, commissions and outward reinsurance premiums. The net operating cash outflows for the nine months ended September 30, 2025, primarily related to payments for the Aviation litigation settlements and claims in respect of the Ukraine Conflict, including the judgment handed down by the English High Court, and for the California wildfire claims, exceeding premium receipts, commissions and outward reinsurance premiums.
Net cash used in investing activities for the nine months ended September 30, 2026, reflected the use of cash to purchase fixed maturity securities and other investments, partially offset by proceeds from the sales and maturities of fixed maturity securities. Cash provided by investing activities for the nine months ended September 30, 2025 reflected the proceeds from the maturities and sales of fixed maturity securities related to the payments for settlements and claims, partially offset by use of cash to purchase fixed maturity securities.
Cash used in financing activities in the nine months ended September 30, 2026, primarily consisted of cash outflows of $362.5 million from common share repurchases, $125.0 million from the redemption of junior notes and $38.0 million from dividends paid to common shareholders. Cash provided by financing activities in the nine months ended September 30, 2025, primarily consisted of cash inflows of $393.3 million from the proceeds from issuance of debt, net of issuance costs, partially offset by cash outflows of $142.7 million from common share repurchases, $59.6 million from the repurchase of preferred securities and $37.4 million from dividends paid to common shareholders.
Letter of Credit Facilities
We routinely enter into agreements with financial institutions to obtain secured and unsecured letter of credit facilities. These facilities are primarily used for the issuance of letters of credit to certain reinsurance entities which require us to post collateral. This is in order for these reinsurance counterparties to be able to take credit under local insurance regulations for the reinsurance protection obtained from companies located in jurisdictions which are not licensed or otherwise admitted as an insurer.
The following table summarizes the outstanding letters of credit at September 30, 2026:
BankCommitmentIn UseSecured by collateral
Lloyds Bank plc$135.0 $36.8 $42.5 
Citibank N.A. London Branch70.0 14.2 15.9 
Barclays Bank plc135.0 44.1 44.4 
Bank of Montreal— 1.9 2.7 
Total$340.0 $97.0 $105.5 
38


Quantitative and Qualitative Disclosures about Market Risk
We believe that we are principally exposed to the following types of market risk: interest rate risk, foreign currency risk and equity price risk.
Interest Rate Risk. Our investment portfolio consists primarily of fixed maturity securities. Fluctuations in interest rates have a direct impact on the market valuation of these securities. Accordingly, our primary market risk exposure is to changes in interest rates. As interest rates rise, the market value of our fixed maturity portfolio falls and the converse is also true.
We manage interest rate risk by maintaining a portfolio of fixed maturity securities where the duration of the portfolio broadly matches the duration of our liabilities in order to reduce the net economic impact from changes in interest rates. At September 30, 2026, our fixed maturity portfolio had an approximate duration of 3.0 years.
The following table summarizes the effect that an immediate, parallel shift in the interest rate yield curve would have on the market value of our fixed maturity securities, available-for-sale, short-term investments, available-for-sale, and fixed income funds at September 30, 2026:
Interest Rate Shift in Basis Points-100-50050100
Market Value$3,431.9 $3,382.8 $3,334.2 $3,286.1 $3,238.6 
Gain/(Loss)$97.7 $48.6 — $(48.1)$(95.6)
Percentage of portfolio at September 30, 2026
2.9%1.5%—(1.4%)(2.9%)
Foreign Currency Risk: Our reporting currency and functional currency is the U.S. dollar. At September 30, 2026, 97.4% of our cash and investments was held in U.S. dollars (December 31, 2025: 97.4%), with the balance of 2.6% held primarily in Euros and British Pound Sterling (December 31, 2025: 2.6%).
Other foreign currency amounts are remeasured to the appropriate functional currency and the resulting foreign exchange gains or losses are reflected in the income statement. Both the remeasurement and translation are calculated using current exchange rates for the balance sheets and monthly exchange rates for the income statements. We may experience exchange losses to the extent that our foreign currency exposure is not properly managed or otherwise hedged, which would in turn adversely affect our results of operations and financial condition. An increase or decrease of 10% in the U.S. dollar would result in an additional gain or loss for the period ended September 30, 2026 of $6.5 million (December 31, 2025: $3.1 million) with an equal impact on net assets, assuming all other assumptions remain unchanged.
We will continue to manage our foreign currency risk by seeking to match our liabilities under insurance and reinsurance policies that are payable in foreign currencies with investments that are denominated in those currencies. This may involve the use of foreign exchange contracts from time to time. A foreign exchange contract involves an obligation to purchase or sell a specified currency at a future date at a price set at the time of the contract. Foreign exchange contracts will not eliminate fluctuations in the value of our assets and liabilities denominated in foreign currencies but rather allow us to establish a rate of exchange for a future point in time.
As the foreign exchange contracts settle, the realized gain or loss is included with foreign exchange gains and losses in the income statement. For the three and nine months ended September 30, 2026, the amount recognized within foreign exchange gains and losses for settled foreign exchange contracts was a realized loss of $(0.7) million and $(0.1) million, respectively, (2025: $(4.7) million and $(16.7) million).
Equity price risk: Our investment portfolio includes hedge funds which have exposure to equity price risk, which is the potential loss arising from decreases in fair value. At September 30, 2026, the fair value of investments with direct exposure to equity price risk totaled $338.5 million (December 31, 2025: $205.8 million). An immediate hypothetical 10% decline in the value of each position would reduce the fair value of such investments by $33.9 million. A hypothetical 10% increase in the value of each position would increase the fair value of such investments by $33.9 million.
Cautionary Note Regarding Forward-Looking Statements
The above discussion contains “forward-looking statements” which include all statements that do not relate solely to historical or current facts and which may concern our strategy, plans, targets, projections or intentions and are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “continue,” “grow,” “opportunity,” “create,” “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “target,” “tracking,” “expect,” “evolve,” “achieve,” “remain,” “proactive,” “pursue,” “optimize,” “emerge,” “build,” “looking ahead,” “commit,” “strategy,” “predict,” “potential,” “assumption,” “future,” “likely,” “may,” “should,” “could,” “will” and the negative of these and also similar terms and phrases. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are qualified by these cautionary statements, because they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, targets, projections, anticipated events and trends, the economy and other future conditions, but are subject to significant business, economic, legal and competitive uncertainties, many of
39


which are beyond our control or are subject to change. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.
Forward-looking statements contained therein may include, among others, statements in relation to: targeted operating results such as return on equity, net income and earnings per share, underwriting profitability and target combined, loss and expense ratios, growth in gross premiums written and book value per share; our expectations regarding current settlement discussions, court cases and current settlement and litigation strategies; our expectations regarding our business, including the industries we operate in, and capital management strategy and the performance of our business; information regarding our estimates for catastrophes, claims and other loss events; our expectations regarding our partnerships and strategic agreements, including The Fidelis Partnership; anticipated market conditions, pricing cycles, and competitive positioning; sustainability and renewable energy initiatives; use of and exposure to emerging technologies; our management team and human capital; our share price performance and valuation; and our regulatory or listing status; our liquidity and capital resources; and expectations of the effect on our results of operations and financial condition of our loss claims, litigation, climate change impacts, contingent liabilities and governmental and regulatory investigations and proceedings.
Our actual results in the future could differ materially from those anticipated in any forward-looking statements as a result of changes in assumptions, risks, uncertainties and other factors impacting us, many of which are outside our control, including:
•the inherent uncertainty, volatility and unpredictability of underwriting insurance and reinsurance risks, including low-frequency, high-severity events and natural and non-natural catastrophic events;
•the frequency and severity of claims and loss activity, including the impact of climate change, inflation (including social inflation), emerging claims trends and complex causation or coverage issues;
•limitations in available data and the reliability of pricing, accumulation, catastrophe and other analytical models used to estimate losses and exposures;
•the adequacy of our loss reserves and the actual development of losses and loss adjustment expenses;
•our ability to manage risks associated with macroeconomic, geopolitical and market conditions, sanctions and other global developments, including escalation of tensions in Ukraine (including the Black Sea), or the Middle East;
•cyclical changes in the insurance and reinsurance industry, including premium rate movements, competitive pressures and consolidation;
•our ability to implement our strategy, identify and execute growth opportunities and compete effectively;
•any downgrades, potential downgrades or other negative actions by rating agencies;
•the availability, affordability and collectability of reinsurance and retrocessional protections;
•litigation, arbitration and regulatory proceedings and the inherent uncertainty of their outcomes;
•our reliance on TFP and other third parties for underwriting, claims handling and other services, and the effectiveness of our risk management and oversight framework;
•operational risks, including system failures, cybersecurity incidents, data protection breaches and risks associated with emerging technologies, including artificial intelligence, and evolving regulatory requirements applicable thereto;
•risks relating to our investment portfolio, including market volatility, interest rate movements, credit risk, liquidity risk and currency fluctuations;
•our ability to access capital and liquidity, including through letters of credit and other financing arrangements, and our status as a holding company dependent on dividends and other distributions from our operating subsidiaries;
•regulatory developments, including changes in capital regimes, increased supervisory scrutiny and compliance with economic and trade sanctions, anti-bribery and similar laws;
•tax developments, including changes in tax laws, interpretations and international tax initiatives;
•our ability to attract and retain key personnel;
•our potential inability to pay dividends or distributions in accordance with our dividend policy;
•our ability to maintain the listing of our common shares on the NYSE or another national securities exchange;
•the Company’s status as a foreign private issuer; and
•the other risks, uncertainties and other factors disclosed under the section titled ‘Risk Factors’ in our Annual Report on Form 20-F filed with the SEC on March 5, 2026, as well as subsequent current reports and other filings with the SEC available electronically at www.sec.gov.
40


The foregoing factors should not be construed as exhaustive and should be read together with the other cautionary statements included in our filings with the SEC. All forward-looking statements included herein are expressly qualified in their entirety by the cautionary statements contained or referred to therein. The forward-looking statements contained herein are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond our control and which could cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements, expectations, beliefs and projections made by us herein speak only as of the date referenced on such date on which they are made and are expressed in good faith and our management believes that there is reasonable basis for them, based only on information currently available to us. There can be no assurance that management’s expectations, beliefs, and projections will be achieved and actual results may vary materially from what is expressed or indicated by the forward-looking statements. Furthermore, our past performance, and that of our management team and of TFP, should not be construed as a guarantee of future performance. Except to the extent required by applicable laws and regulations, we undertake no obligation to update or revise any forward-looking statements contained in the above discussion, whether as a result of new information, future developments or otherwise. In light of these risks and uncertainties, you should keep in mind that any event described in a forward-looking statement might not occur.
41
Q3 2026 Earnings Presentation


 

This presentation contains “forward-looking statements” which include all statements that do not relate solely to historical or current facts and which may concern our strategy, plans, targets, projections or intentions and are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “continue,” “grow,” “opportunity,” “create,” “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “target,” “tracking,” “expect,” “evolve,” “achieve,” “remain,” “proactive,” “pursue,” “optimize,” “emerge,” “build,” “looking ahead,” “commit,” “strategy,” “predict,” “potential,” “assumption,” “future,” “likely,” “may,” “should,” “could,” “will” and the negative of these and also similar terms and phrases. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are qualified by these cautionary statements, because they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, targets, projections, anticipated events and trends, the economy and other future conditions, but are subject to significant business, economic, legal and competitive uncertainties, many of which are beyond our control or are subject to change. Our actual results and financial condition may differ materially from those indicated in the forward- looking statements. Therefore, you should not rely on any of these forward-looking statements. Forward-looking statements contained therein may include, among others, statements in relation to: targeted operating results such as return on equity, net income and earnings per share, underwriting profitability and target combined, loss and expense ratios, growth in gross premiums written and book value per share; our expectations regarding current settlement discussions, court cases and current settlement and litigation strategies; our expectations regarding our business, including the industries we operate in, and capital management strategy and the performance of our business; information regarding our estimates for catastrophes, claims and other loss events; our expectations regarding our partnerships and strategic agreements, including The Fidelis Partnership; anticipated market conditions, pricing cycles, and competitive positioning; sustainability and renewable energy initiatives; use of and exposure to emerging technologies; our management team and human capital; our share price performance and valuation; and our regulatory or listing status; our liquidity and capital resources; and expectations of the effect on our results of operations and financial condition of our loss claims, litigation, climate change impacts, contingent liabilities and governmental and regulatory investigations and proceedings. Our actual results in the future could differ materially from those anticipated in any forward-looking statements as a result of changes in assumptions, risks, uncertainties and other factors impacting us, many of which are outside our control, including: the inherent uncertainty, volatility and unpredictability of underwriting insurance and reinsurance risks, including low-frequency, high-severity events and natural and non-natural catastrophic events; the frequency and severity of claims and loss activity, including the impact of climate change, inflation (including social inflation), emerging claims trends and complex causation or coverage issues; limitations in available data and the reliability of pricing, accumulation, catastrophe and other analytical models used to estimate losses and exposures; the adequacy of our loss reserves and the actual development of losses and loss adjustment expenses; our ability to manage risks associated with macroeconomic, geopolitical and market conditions, sanctions and other global developments, including escalation of tensions in Ukraine (including the Black Sea), or the Middle East; cyclical changes in the insurance and reinsurance industry, including premium rate movements, competitive pressures and consolidation; our ability to implement our strategy, identify and execute growth opportunities and compete effectively; any downgrades, potential downgrades or other negative actions by rating agencies; the availability, affordability and collectability of reinsurance and retrocessional protections; litigation, arbitration and regulatory proceedings and the inherent uncertainty of their outcomes; our reliance on TFP and other third parties for underwriting, claims handling and other services, and the effectiveness of our risk management and oversight framework; operational risks, including system failures, cybersecurity incidents, data protection breaches and risks associated with emerging technologies, including artificial intelligence, and evolving regulatory requirements applicable thereto; risks relating to our investment portfolio, including market volatility, interest rate movements, credit risk, liquidity risk and currency fluctuations; our ability to access capital and liquidity, including through letters of credit and other financing arrangements, and our status as a holding company dependent on dividends and other distributions from our operating subsidiaries; regulatory developments, including changes in capital regimes, increased supervisory scrutiny and compliance with economic and trade sanctions, anti-bribery and similar laws; tax developments, including changes in tax laws, interpretations and international tax initiatives; our ability to attract and retain key personnel; our potential inability to pay dividends or distributions in accordance with our dividend policy; our ability to maintain the listing of our common shares on the NYSE or another national securities exchange; the Company’s status as a foreign private issuer; and the other risks, uncertainties and other factors disclosed under the section titled ‘Risk Factors’ in our Annual Report on Form 20-F filed with the SEC on March 5, 2026, as well as subsequent current reports and other filings with the SEC available electronically at www.sec.gov. The foregoing factors should not be construed as exhaustive and should be read together with the other cautionary statements included in our filings with the SEC. All forward-looking statements included herein are expressly qualified in their entirety by the cautionary statements contained or referred to therein. The forward-looking statements contained herein are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond our control and which could cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements, expectations, beliefs and projections made by us herein speak only as of the date referenced on such date on which they are made and are expressed in good faith and our management believes that there is reasonable basis for them, based only on information currently available to us. There can be no assurance that management’s expectations, beliefs, and projections will be achieved and actual results may vary materially from what is expressed or indicated by the forward-looking statements. Furthermore, our past performance, and that of our management team and of TFP, should not be construed as a guarantee of future performance. Except to the extent required by applicable laws and regulations, we undertake no obligation to update or revise any forward-looking statements contained in the above discussion, whether as a result of new information, future developments or otherwise. In light of these risks and uncertainties, you should keep in mind that any event described in a forward-looking statement might not occur. Basis of Presentation Cautionary Note Regarding Forward-Looking Statements 2


 

Pelagos Insurance Capital: At a Glance Note: 1. Results as of September 30, 2026, and gross premiums written for the trailing twelve months (“TTM”) ended September 30, 2026. 2. The financial strength ratings included in this presentation are provided by third-party rating agencies and are subject to adjustment at the sole discretion of those agencies. The presentation does not constitute an endorsement of the ratings by the presenter or any other party. Highlights A strategic capital allocator and expert risk selector in specialty insurance and reinsurance, committed to long-term partnerships. 3 $13.4 bn Total Assets $2.1 bn Shareholders’ Equity $4.2 bn Cash & Invested Assets $5.0 bn Gross Premiums Written Financial Strength Rating A AM Best Stable Outlook A- S&P Stable Outlook A3 Moody’s Stable Outlook 18% 2% 4% 4% 4% 11% 12% 17% 27% $938m (19%) INSURANCE $4,017m (81%) $5.0 Billion REINSURANCE Retro & Whole Account Cyber Aviation & Aerospace Political Risk, Violence & Terror Energy 1% Property Marine Property Reinsurance Asset Backed Finance & Portfolio Credit Gross Premiums Written(1) Other Insurance


 

$16.24 $20.69 $21.79 $24.61 $26.60$0.40 $0.90 $1.35 2022 2023 2024 2025 Sep 30, 2026 2026 Third Quarter Key Takeaways 4 • Growth continues to highlight the advantages of our capital allocator model, with gross premiums written up 5.3%, driven by our broadening network of underwriting partners and targeted deployment into attractive opportunities. • Our strong capital position provides flexibility to pursue profitable underwriting opportunities while returning capital to shareholders. We continued our track record of returning capital to shareholders in the third quarter, returning $95 million, including common share repurchases of $83 million and dividends of $12 million. • Disciplined execution and capital allocation continue to drive shareholder value, with book value per diluted common share increasing 16% from the third quarter of 2025, including dividends, to $26.60. $3.0 $3.6 $4.4 $4.7 $5.0 2022 2023 2024 2025 TTM Q3 2026 Gross Premiums Written +67% Book Value Cumulative Common Dividends Book Value Per Diluted Common Share +72% (1) (1) As of the Separation Transactions on January 3, 2023. $ in billions


 

Key Quarterly Highlights 2026 Third Quarter Highlights Note: 1. See Appendix for definitions and reconciliations of non-GAAP financial measures. Q3 2025 QTD Q3 2026 QTD Gross Premiums Written $798M $840M Net Premiums Earned $600M $784M Combined Ratio 79.0% 91.5% Annualized Operating ROAE(1) 21.4% 15.3% Operating Net Income(1) $127M $83M Net Investment Income $46M $45M Operating EPS(1) $1.21 $1.00 • Gross premiums written growth of $42 million or 5.3% from the third quarter of 2025, driven by our Insurance segment. • Combined ratio of 91.5%, compared with particularly benign loss experience in the third quarter of 2025. • Annualized Operating ROAE of 15.3% for the quarter • Net investment income remained consistent. • Returned $95 million of capital to common shareholders in the three months ended September 30, 2026, including common share repurchases of $83 million and dividends of $12 million. Common share repurchases included $44 million executed in the open market and $39 million through privately negotiated transactions. 5


 

Key Year-to-Date Highlights 2026 Year-to-Date Highlights Note: 1. See Appendix for definitions and reconciliations of non-GAAP financial measures. Q3 2025 YTD Q3 2026 YTD Gross Premiums Written $3,739M $3,977M Net Premiums Earned $1,741M $1,933M Combined Ratio 99.5% 92.4% Annualized Operating ROAE(1) 5.2% 11.8% Operating Net Income(1) $95M $200M Net Investment Income $140M $132M Operating EPS(1) $0.88 $2.30 December 31, 2025 September 30, 2026 Book Value Per Diluted Share $24.61 $26.60 Total Assets $12.4B $13.4B Total Shareholders' Equity $2.4B $2.1B • Gross premiums written growth of $238 million or 6.4% compared to the first nine months of 2025, primarily driven by growth from our network of expanded underwriting partners. • Combined ratio of 92.4%, an improvement of 7 points compared to 99.5% in the first nine months of 2025 • Annualized Operating ROAE of 11.8%, an improvement of 7 points compared to the first nine months of 2025 • Net investment income decrease was primarily driven by lower investable assets compared to the prior year period. • Book value per diluted common share was $26.60 at September 30, 2026, an increase of 8.1% from December 31, 2025, of $24.61. • Returned $401 million of capital to common shareholders in the nine months ended September 30, 2026, including common share repurchases of $363 million and dividends of $38 million. Common share repurchases included $107 million executed in the open market and $255 million through privately negotiated transactions. 6


 

77.3% 70.0% 89.7% 81.9% 83.0% 82.2% 51.0% 42.8% 57.9% 52.5% 52.6% 52.3% 26.3% 27.2% 31.8% 29.4% 30.4% 29.9% Loss Ratio Policy Acquisition Expense Ratio 2022 2023 2024 2025 Q3 2025 YTD Q3 2026 YTD $2,413 $2,960 $3,539 $3,756 $2,775 $3,036 2022 2023 2024 2025 Q3 2025 YTD Q3 2026 YTD 7 Insurance Note: 1. Underwriting Ratio is calculated by dividing losses and loss adjustment expenses and policy acquisition expenses (excluding TFP commissions) by net premiums earned. The Fidelis Partnership commissions are not allocated to the segment level and policy acquisition costs as presented in the underwriting ratio are third party acquisition costs. Gross Premiums Written Segment Highlights Underwriting Ratio(1) • Gross premiums written increased by 9% year-to-date primarily driven by growth from our network of expanded underwriting partners, in several lines of business, partially offset by a non-renewal in our Cyber line of business that did not meet our underwriting criteria and rating hurdles. • Loss ratio was consistent with the prior year period. improved by 0.3 points year-to-date • Policy acquisition expense ratio was consistent with the prior year period. $ in millions


 

97.4% 36.5% 38.9% 50.0% 76.0% 28.8%75.0% 9.3% 15.3% 23.7% 49.9% (0.9)% 22.4% 27.2% 23.6% 26.3% 26.1% 29.7% Loss Ratio Policy Acquisition Expense Ratio 2022 2023 2024 2025 Q3 2025 YTD Q3 2026 YTD $605 $619 $865 $961 $964 $941 2022 2023 2024 2025 Q3 2025 YTD Q3 2026 YTD 8 Reinsurance Note: 1. Underwriting Ratio is calculated by dividing losses and loss adjustment expenses and policy acquisition expenses (excluding TFP commissions) by net premiums earned. The Fidelis Partnership commissions are not allocated to the segment level and policy acquisition costs as presented in the underwriting ratio are third party acquisition costs. 2. The catastrophe and large losses for the year ended December 31, 2022, related to Hurricane Ian, Australian floods and European storms. • Gross premiums written decreased by 2% year-to-date primarily from reinstatement premiums related to the California wildfires in the prior year period and the restructuring of a client's program. The decrease was partially offset by targeted deployment into areas where we continue to see attractive risk-adjusted returns. • Loss ratio improved by 50.8 points year-to-date driven by no material catastrophe and large losses in the current year period, compared to the California wildfires in the prior year period. • Policy acquisition expense ratio increased by 3.6 points year-to-date primarily due to business mix and changes in ceded premium and commissions earned from outwards reinsurance partners. $ in millions Gross Premiums Written Segment Highlights Underwriting Ratio(1) (2)


 

$50.6 $46.5 $44.2 $70.4 $35.6 $150.4 $150.2 Net Investment Income Realized and Unrealized Gains on Other Investments Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q3 2025 YTD Q3 2026 YTD • For the three and nine months ended September 30, 2026, we generated net investment income of $44.6 million and $132.3 million, respectively, at an average annualized yield of 4.6% and 4.3%, respectively (2025: $45.9 million and $140.0 million at an average annualized yield of 4.5% and 4.4%). • As of September 30, 2026, 91% is comprised of cash and cash equivalents, restricted cash and cash equivalents, fixed maturities, short-term securities and fixed income funds. • Overall book yield of 4.9% reflects steps taken to optimize portfolio. High Quality and Diversified Investment Portfolio 9 Note: 1. Realized and Unrealized Gains on Other Investments primarily relates to our strategic deployment of assets into alternative investments, including a hedge fund portfolio. 2. Includes investments in our fixed income funds. Asset Allocation As of September 30, 2026 $3.3 bn Fixed Income Portfolio(2) 3.0 yrs Duration A+ Weighted-Average Credit Quality ~86% Rated A or Better 41% Corporates 9% Hedge Funds 10% Agency MBS7% Other ABS 14% U.S. Treasuries 12% Cash $4.2 bn Investment Portfolio Highlights Net Investment Income & Realized and Unrealized Gains on Other Investments(1) 6% Fixed Income Funds <1% Private Credit Funds


 

10 • Committed to a strategic and disciplined approach to capital allocation to maintain financial strength and drive profitable underwriting. • Ample liquidity to pursue growth and return capital to shareholders. • Long-term debt comprised: ◦ $400 million 7.750% Subordinated Notes, due 2055 ◦ $330 million 4.875% Senior Notes, due 2030 • Since the inception of our share repurchase program in 2024, our strategic approach to share repurchases has contributed $2.23 to our book value per share. Capital Management HighlightsCapital Strength and Balance Sheet Scale Strong Capital Position and Disciplined Approach to Capital Allocation $865.9 $280.0 $449.4 $136.5 Common share dividends Privately negotiated share repurchases Open market share repurchases $2,862.0 $2,141.2 $720.8 Long-term debt Common equity Note: 1. As of September 30, 2026. 2. Includes pro rata shares repurchased from The Fidelis Partnership. 3. Dividend yield is the annualized Q3 2026 dividend divided by $27.73, the closing share price as of November 6, 2026. 4. As of November 3, 2026. As of September 30, 2026 ($ in millions) Capital Management Inception to Date As of September 30, 2026 ($ in millions) (2) 25.2% Debt-to-Capital Ratio(1) $0.22 Quarterly dividend $400.0 million Share repurchase authorization remaining(4) 3.2% Dividend Yield(3) (2)


 

Expert capital allocator and risk selector with a leading diversified specialty insurance and reinsurance portfolio Expanding network of experienced long-term underwriting partners provides differentiated access points to attractive risks which best fit our strategic priorities Demonstrated track record of growth and book value creation through the cycle with 72%(1) increase in book value per share since 2022 Strong capital position offers the flexibility to enhance shareholder returns while continuing to pursue compelling growth opportunities Pelagos Insurance Capital brings together strategic capital, expert risk selection and specialist underwriting expertise to create long-term value for shareholders 11 Highly experienced and connected leadership team with decades of deep relationships in the market Note: 1. Book value diluted common share growth as of January 3, 2023, the date on which a number of separation and reorganization transactions occurred to create two distinct holding companies and businesses: Pelagos Insurance Capital and The Fidelis Partnership (the “Separation Transactions”) through September 30, 2026, and includes accumulated dividends to common shareholders of $1.35. See slide 4 for further details. Why Invest in Pelagos Insurance Capital


 

Appendix


 

Non-GAAP Financial Measures Reconciliation Three months ended Nine months ended ($ in millions except for share and per share amounts) September 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025 Net income $ 61.7 $ 130.5 $ 214.1 $ 107.7 Adjustment for net realized and unrealized investment (gains)/losses 27.4 (6.2) 4.1 (18.8) Adjustment for net foreign exchange (gains)/losses (2.0) 1.7 2.0 2.2 Adjustment for corporate and other expenses 0.3 — 3.0 1.2 Income tax (benefit)/expense (1) (4.1) 0.8 (22.8) 2.9 Operating net income $ 83.3 $ 126.8 $ 200.4 $ 95.2 Average common shareholders' equity $ 2,180.9 $ 2,369.8 $ 2,270.4 $ 2,432.3 Weighted average common shares outstanding 81,899,656 104,370,380 86,384,660 108,156,265 Share-based compensation plans 1,122,539 635,750 777,361 479,643 Weighted average diluted common shares outstanding 83,022,195 105,006,130 87,162,021 108,635,908 Annualized ROAE 11.3 % 22.0 % 12.6 % 5.9 % Annualized Operating ROAE 15.3 % 21.4 % 11.8 % 5.2 % Earnings per diluted common share $ 0.74 $ 1.24 $ 2.46 $ 0.99 Operating EPS $ 1.00 $ 1.21 $ 2.30 $ 0.88 13 This Presentation includes certain financial measures that are not calculated in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) including operating net income, operating EPS, operating return on average common equity, and therefore are non-GAAP financial measures. Reconciliations of such measures to the most comparable GAAP figures are included in the attached financial information in accordance with Regulation G. Operating net income is a non-GAAP financial measure of our performance which does not consider the impact of certain non-recurring and other items that may not properly reflect the ordinary activities of our business, its performance or its future outlook. This measure is calculated as net income excluding net realized and unrealized investment gains/(losses), net foreign exchange gains/ (losses), corporate and other expenses, and the income tax effect on these items. Annualized operating return on average common equity (“Annualized Operating ROAE”) is a non-GAAP financial measure that represents a meaningful comparison between periods of our financial performance expressed as a percentage and is calculated as annualized operating net income divided by average common shareholders’ equity. Operating earnings per share (“Operating EPS”) is a non-GAAP financial measure that represents a valuable measure of profitability and enables investors, analysts, rating agencies and other users of our financial information to more easily analyze our results in a manner similar to how management analyzes its underlying business performance. It is calculated by dividing operating net income by the weighted average diluted common shares outstanding. (1) Income tax (benefit)/expense on adjustments to net income/(loss). The income tax benefit for the nine months ended September 30, 2026 includes the reversal of a U.K. top-up tax charge of $21.4 million.


 

W: pelagosinsurancecapital.com T: +1 441 279 2590 Wellesley House South 4th Floor, 90 Pitts Bay Road, Pembroke HM 08 Bermuda


 

Filing Exhibits & Attachments

8 documents

Keep reading